http://prostatecancerinfolink.net/2012/02/13/years-of-life-lost-due-to-prostate-cancer-in-the-usa-1972-2006/2012-02-14T02:28:48+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/10/korean-study-says-that-hifu-does-not-provide-effective-oncologic-outcomes/2012-02-13T16:05:01+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/11/how-am-i-meant-to-get-there-from-here/2012-02-12T22:40:37+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/10/the-potential-of-mva-5t4-as-treatment-for-advanced-prostate-cancer/2012-02-11T23:01:45+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/09/problems-with-enrollment-into-ongoing-phase-iii-trials-of-new-drugs-for-men-with-mcrpc/2012-02-09T16:45:32+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/09/does-coronary-artery-disease-increase-risk-for-a-diagnosis-of-prostate-cancer/2012-02-12T15:40:45+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/08/advisory-panel-does-not-recommend-approval-of-xgeva-for-prevention-of-bone-mets/2012-02-08T21:16:04+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/08/can-high-levels-of-dietary-calcium-lower-risk-for-prostate-cancer/2012-02-10T16:44:41+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/07/occurrence-of-infections-and-hospitalizations-in-men-having-prostate-biopsy-in-europe/2012-02-09T13:45:52+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/06/will-densoumab-gain-approval-for-prevention-of-onset-of-metastasis-to-bone/2012-02-09T21:01:43+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/06/long-term-use-of-abiraterone-acetate-at-250-mgd-is-this-really-viable/2012-02-10T22:17:34+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/05/other-interesting-presentations-from-the-gu-oncology-meeting-part-ii/2012-02-05T16:46:32+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/03/other-interesting-presentations-from-the-gu-oncology-meeting-part-i/2012-02-12T14:36:53+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/03/educational-updates-from-the-gu-oncology-symposium/2012-02-03T13:17:54+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/02/nice-initially-refuses-to-cover-cost-of-abiraterone-acetate-for-mcrpc/2012-02-04T12:12:43+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/02/brachytherapy-is-it-really-better-as-a-first-line-treatment-for-low-and-intermediate-risk-prostate-cancer/2012-02-02T19:08:19+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/02/vigorous-exercise-may-prevent-progression-of-low-risk-prostate-cancer/2012-02-04T18:11:32+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/01/first-directly-comparative-data-question-safety-of-pbrt-vs-imrt/2012-02-02T19:13:00+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/01/side-effect-profile-of-mdv3100-appears-highly-promising-in-mcrpc/2012-02-02T02:14:43+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/01/full-agenda-and-abstracts-for-genitourinary-cancer-symposium-now-available/2012-02-01T21:17:05+00:00monthlyhttp://prostatecancerinfolink.net/2012/02/01/expanded-access-trial-in-development-for-radium-223-chloride-alpharadin-in-mcrpc/2012-02-01T12:38:14+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/31/ralp-not-associated-with-better-continence-sexual-function-after-prostate-cacner-surgery/2012-02-01T18:31:15+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/31/still-no-sufficient-evidence-to-support-any-widespread-prostate-cancer-prevention-strategy/2012-01-31T16:53:19+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/27/ahrq-responds-to-letter-from-prostate-cancer-roundtable/2012-01-31T22:35:57+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/26/the-walnuts-are-back-in-vogue-at-least-with-mice/2012-01-27T02:51:01+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/25/the-value-of-mri-prior-to-surgery-as-a-treatment-for-localized-prostate-cancer/2012-01-26T02:58:28+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/25/sebelius-has-not-overruled-uspstf-recommendation-after-all/2012-01-26T03:01:32+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/24/dutasteride-as-a-single-agent-for-low-risk-prostate-cancer/2012-01-26T16:30:55+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/23/tasquinimod-cabazitaxel-in-heavily-pre-treated-men-with-mcrpc/2012-01-24T02:59:06+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/20/new-jersey-passes-legislation-against-uspstf-recommendation-on-prostate-cancer-screening/2012-01-28T00:39:08+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/21/has-sebelius-overruled-uspstf-recommendation-on-psa-screening/2012-01-24T22:51:27+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/19/sequencing-of-treatment-with-new-therapeutic-agents-for-advanced-prostate-cancer/2012-01-20T19:42:52+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/19/the-future-of-focal-therapy/2012-01-19T23:05:13+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/18/an-update-on-views-about-the-uspstf-recommendation-and-prostate-cancer-screening/2012-01-20T03:37:49+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/18/will-active-surveillance-save-us-money-in-management-of-prostate-cancer/2012-01-19T11:40:38+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/17/trips-trip-10-years-of-battling-metastatic-prostate-cacner/2012-02-07T20:21:07+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/17/self-referral-and-the-role-of-imrt-in-treatment-of-prostate-cancer/2012-01-18T14:16:39+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/16/peripheral-androgen-deprivation-for-men-with-a-rising-psa-after-surgery-andor-radiation-therapy/2012-01-17T22:31:43+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/15/a-small-multi-center-cohort-study-of-sbrt-in-treatment-of-low-risk-prostate-cancer/2012-01-15T23:17:12+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/14/increasing-focus-on-the-appropriate-definition-and-management-of-prostate-cancer/2012-01-23T10:53:38+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/13/biopsy-in-d-minor-by-johann-sebastian-you-know-who/2012-01-31T02:13:39+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/12/nice-says-no-to-cabazitaxel-in-the-uk-at-least-for-the-moment/2012-01-14T00:05:48+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/12/single-genetic-mutation-predicts-one-rare-form-of-hereditary-prostate-cancer/2012-01-13T12:45:10+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/12/the-scientific-basis-for-psa-monitoring-after-first-line-treatment-for-localized-prostate-cancer/2012-02-03T19:50:15+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/11/how-to-select-the-optimal-therapy-for-early-stage-prostate-cancer/2012-01-12T15:13:00+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/10/are-us-urologists-really-acceptant-of-active-surveillance/2012-01-13T18:04:16+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/10/genomic-health-initiates-validation-study-of-multi-gene-test-for-prostate-cancer/2012-01-11T15:16:20+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/06/astro-claims-proton-therapy-effective-prostate-cancer-treatment/2012-01-09T20:51:49+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/09/mortality-rates-at-13-years-of-follow-up-in-the-plco-study/2012-01-11T18:11:26+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/09/full-results-of-the-affirm-trial-at-gu-oncology-meeting-next-month/2012-01-09T20:44:09+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/09/robot-assisted-surgery-is-not-necessarily-better-than-open-surgery/2012-01-12T04:26:23+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/06/prognostic-factors-for-men-with-primary-signet-ring-cancer-of-the-prostate/2012-01-06T14:13:23+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/06/patient-satisfaction-after-first-line-treatment-for-localized-prostate-cancer-in-germany/2012-01-06T15:25:31+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/05/taregted-therapy-and-companion-diagnostic-the-aezs-108-story/2012-01-05T20:10:23+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/05/long-term-psa-based-risk-for-prostate-cancer/2012-01-06T00:48:42+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/05/acs-projects-incidence-and-mortality-data-for-2012/2012-01-05T22:25:25+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/04/the-end-of-epca-1-and-epca-2-as-a-diagnosticprognostic-test-for-prostate-cancer/2012-01-04T17:12:27+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/03/if-you-want-pbrt-be-so-good-as-to-enter-a-clinical-trial/2012-01-04T17:41:57+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/03/just-more-deja-vu-all-over-again/2012-01-04T02:35:52+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/02/out-with-the-old-in-with-the-new/2012-01-02T13:27:55+00:00monthlyhttp://prostatecancerinfolink.net/2012/01/01/the-new-prostate-cancer-infolink-2011-in-review/2012-01-27T19:56:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/26/a-rare-case-of-angiosarcoma-of-the-prostate/2011-12-28T12:51:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/26/the-new-nccn-patient-guidelines-a-great-improvement-over-last-time/2011-12-29T20:59:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/24/magnesium-oxide-and-prostate-movement-during-radiation-therapy/2011-12-24T17:28:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/23/nccn-issues-completely-revised-edition-of-prostate-cancer-patient-guidelines/2011-12-25T14:00:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/23/the-clinical-significance-of-high-grade-pin-an-update/2011-12-23T14:54:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/20/new-national-prostate-surveillance-project-close-to-going-live/2011-12-21T13:22:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/20/prostate-cancer-risk-an-investigative-journalists-tale/2011-12-21T16:52:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/20/african-american-men-significantly-underestimate-their-risk-of-a-positive-prostate-biopsy/2011-12-20T14:24:54+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/20/nerve-sparing-surgery-and-post-surgical-sexual-function-news-from-kyoto/2011-12-20T13:13:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/19/the-uspstf-communication-and-the-politics-of-cancer-screening-guidance/2011-12-28T02:40:53+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/16/acs-rolls-out-new-process-for-developing-cancer-guidelines/2011-12-17T15:16:03+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/16/dod-cdmrp-funding-and-prostate-cancer-research-for-fy-2012/2011-12-17T04:15:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/15/psa-density-and-the-estimation-of-risk-for-upgrading-of-localized-prostate-cacer/2011-12-21T20:45:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/14/the-patients-expectations-and-the-doctors-dilemmas-3/2011-12-16T12:10:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/14/is-mass-prostate-cancer-screening-even-ethical-in-men-%e2%89%a5-65-years-of-age/2011-12-17T02:52:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/13/cancer-and-prostate-cancer-screening-in-the-elderly/2011-12-19T02:20:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/09/a-new-name-for-some-forms-of-neoplastic-prostate-pathology/2011-12-11T16:24:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/10/regret-post-treatment-in-men-with-pre-existing-cardiovascular-disease/2011-12-10T14:56:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/08/whats-next-on-the-active-surveillance-front/2011-12-11T20:05:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/07/just-what-is-the-real-risk-of-cardiovascular-morbidity-and-mortality-for-men-on-adt/2011-12-07T23:21:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/07/nih-panel-statement-on-active-surveillance-in-prostate-cancer/2011-12-12T19:08:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/05/active-surveillance-for-localized-prostate-cancer-the-state-of-the-science/2011-12-05T13:28:43+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/05/new-data-suggest-that-salvage-hifu-after-ebrt-is-a-high-risk-procedure/2011-12-06T00:21:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/29/informational-event-about-prostate-cancer-screening-on-capitol-hill/2011-12-08T18:48:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/03/re-irradiation-of-the-prostate-after-first-line-radiation-therapy-for-localized-prostate-cancer/2012-01-02T11:35:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/02/hormonal-therapy-and-risk-for-blood-clots-for-men-on-adt/2011-12-05T23:12:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/12/01/public-perception-and-prostate-and-other-cancer-screenings/2011-12-13T12:28:33+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/30/hazard-for-prostate-cancer-specific-mortality-after-radical-prostatectomy/2011-12-01T01:27:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/29/molecular-signatures-and-prediction-of-poor-prostate-cancer-outcomes-over-time/2011-12-01T19:27:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/28/risk-stratification-in-diagnosis-and-management-of-prostate-cancer/2011-12-01T16:53:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/18/nih-state-of-the-science-conference-on-active-surveillance/2011-11-28T02:38:33+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/01/color-doppler-ultrasound-in-the-biopsy-based-diagnosis-of-prostate-cancer/2011-11-25T14:46:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/25/under-diagnosis-of-gleason-pattern-5-prostate-cancer/2011-11-26T02:17:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/24/who-needs-aggressive-treatment-after-initial-radiation-and-who-does-not/2011-11-25T14:34:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/24/the-new-prostate-cancer-infolinks-2011-thanksgiving-report/2011-12-09T12:14:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/23/informed-choice-uninformed-compliance-and-education-about-cancer-screening/2011-12-01T20:42:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/23/celgene-terminates-mailsail-trial-for-lack-of-effectiveness/2011-11-23T14:20:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/22/is-the-word-cancer-out-of-date-whats-in-a-name/2011-11-23T13:29:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/22/the-best-way-to-measure-post-treatment-levels-of-urinary-continence/2011-11-22T14:07:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/22/grk5-and-the-aggressive-growth-of-prostate-cancer-tumors/2011-11-22T12:09:43+00:00monthlyhttp://prostatecancerinfolink.net/treatment/2011-11-21T21:35:27+00:00weekly0.6http://prostatecancerinfolink.net/2008/03/27/prostate-cancer-in-cuba-and-jamaica-as-viewed-from-turks-and-caicos/2011-11-21T20:05:24+00:00monthlyhttp://prostatecancerinfolink.net/2008/03/26/krongrad-prostate-cancer-in-the-caribbean/2011-11-21T17:39:55+00:00monthlyhttp://prostatecancerinfolink.net/2008/03/26/aggressive-prostate-cancer-after-dietary-supplements/2011-11-21T17:38:44+00:00monthlyhttp://prostatecancerinfolink.net/2008/03/23/krongrad-selenium-and-prostate-cancer-prevention/2011-11-21T17:36:41+00:00monthlyhttp://prostatecancerinfolink.net/2008/03/23/surgeon-experience-and-prostate-cancer-surgery/2011-11-21T17:33:48+00:00monthlyhttp://prostatecancerinfolink.net/2008/03/16/dr-arnon-krongrad-blog-prostate-books/2011-11-21T17:18:42+00:00monthlyhttp://prostatecancerinfolink.net/2008/03/17/erection-season/2011-11-21T16:37:21+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/21/acute-and-mid-term-side-effects-of-high-dose-image-guided-imrt-in-first-line-treatment-of-localized-prostate-cancer/2011-11-21T16:43:49+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/21/adjuvant-or-salvage-radiation-for-high-risk-patients-post-surgery-the-need-for-shared-decision-making/2011-11-21T21:43:19+00:00monthlyhttp://prostatecancerinfolink.net/questions/ask-arnon/2012-02-13T17:04:02+00:00weekly0.6http://prostatecancerinfolink.net/2011/11/19/radionuclide-therapy-with-strontium-89-for-relief-of-metastatic-bone-pain/2011-11-21T01:10:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/18/focal-cryotherapy-and-update-from-the-cold-registry/2011-11-18T16:22:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/18/aging-demography-and-the-long-term-risk-for-prostate-cancer/2011-11-18T14:59:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/17/denosumab-and-delay-of-onset-of-bone-metastasis/2011-11-17T11:58:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/15/barvarian-nordic-starts-multi-center-phase-iii-trial-of-prostvac/2011-12-23T11:44:31+00:00monthlyhttp://prostatecancerinfolink.net/tips-tools/views-from-the-other-side/2011-11-16T16:29:02+00:00weekly0.6http://prostatecancerinfolink.net/2011/11/15/this-research-is-speculative-and-definitive-conclusions-cannot-be-drawn/2011-11-16T01:41:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/15/holistic-medicine-and-focal-cryotherapy-are-not-active-surveillance/2011-11-18T06:03:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/14/new-data-on-cabozantinib-xl184-in-men-with-mcrpc/2011-11-14T23:32:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/14/a-multi-specialty-review-of-current-evidence-regarding-prostate-cancer-screening/2011-11-14T17:11:58+00:00monthlyhttp://prostatecancerinfolink.net/2008/06/07/a-note-on-notes/2011-11-14T16:54:39+00:00monthlyhttp://prostatecancerinfolink.net/2008/09/24/the-vagina-may-not-be-your-friend-but/2011-11-14T16:51:17+00:00monthlyhttp://prostatecancerinfolink.net/2009/03/02/krongrad-prostate-cancer-mission-open-conversation/2011-11-14T16:46:32+00:00monthlyhttp://prostatecancerinfolink.net/2009/06/20/a-sudden-squall-about-selenium/2011-11-14T16:43:34+00:00monthlyhttp://prostatecancerinfolink.net/2009/11/23/a-changing-of-the-guard-in-prostate-cancer-research/2011-11-14T16:29:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/06/does-prostatic-inflammation-lead-to-later-prostate-cancer/2011-11-14T16:25:16+00:00monthlyhttp://prostatecancerinfolink.net/tips-tools/2011-11-14T16:23:00+00:00weekly0.6http://prostatecancerinfolink.net/2011/11/14/prostate-cancer-screening-in-germany-curative-or-harmful/2011-11-14T15:44:34+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/11/beware-over-reaction-to-ultrasensitive-psa-doubling-times/2011-11-12T04:52:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/10/aua-issues-full-formal-comments-on-uspstf-draft-recommendation/2011-11-11T03:23:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/10/further-actions-in-the-u-s-congress-re-the-uspstf-recommendation-on-psa-testing/2011-11-10T12:25:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/09/how-magnets-dont-actually-treat-prostate-cancer/2011-11-10T11:42:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/08/letter-to-secretary-sebelius-about-coverage-of-psa-testing-from-members-of-congress/2011-11-09T17:25:58+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/08/and-now-for-prostate-cancer-there-is-an-app-for-that/2011-11-10T16:34:09+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/02/a-medical-oncologists-views-on-the-uspstf-draft-recommendations/2011-11-07T20:13:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/07/more-on-expectant-management-for-screening-detected-prostate-cancer/2011-11-07T23:03:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/07/tadalafil-for-ed-after-first-line-radiation-therapy-for-prostate-cancer/2011-11-07T14:38:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/05/is-leucine-blockade-an-important-new-approach-to-prostate-cancer-management/2011-11-06T14:54:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/04/the-value-of-exercise-in-prostate-cancer-management/2011-11-05T20:46:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/04/lack-of-transparency-re-public-input-to-uspstf-is-rather-sad/2011-11-05T21:02:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/03/mdv3100-shows-survival-benefit-in-phase-iii-affirm-trial/2011-11-03T17:55:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/03/ralp-as-a-first-line-treatment-for-high-risk-localized-and-locally-advanced-prostate-cancer/2011-11-03T16:23:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/03/ebrt-total-combined-adt-in-treatment-of-high-risk-localized-and-locally-advanced-prostate-cancer/2011-11-03T14:24:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/02/2000-year-old-mummy-found-to-have-metastatic-prostate-cancer/2011-11-03T00:20:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/11/01/two-phase-iii-trials-planned-for-cabozantinib-in-mcrpc/2011-11-01T11:52:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/31/potential-future-agents-in-the-management-of-mcrpc/2011-11-01T10:17:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/31/roundtable-issues-media-release-re-uspstf-recommendation/2011-11-02T13:22:47+00:00monthlyhttp://prostatecancerinfolink.net/tips-tools/pick-surgeon/2011-10-31T03:44:39+00:00weekly0.6http://prostatecancerinfolink.net/treatment/first-line-localized/surgery/lrp/2011-10-31T03:40:47+00:00weekly0.6http://prostatecancerinfolink.net/2011/10/29/the-uspstf-recommendation-a-cartoonists-perspective/2011-10-30T02:02:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/28/survey-suggests-high-level-of-long-term-side-effects-after-treatment-for-prostate-cancer/2011-11-11T15:40:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/28/prostate-cancer-roundtable-comments-on-uspstf-recommendation/2011-10-28T16:42:39+00:00monthlyhttp://prostatecancerinfolink.net/questions/2011-10-28T03:23:20+00:00weekly0.6http://prostatecancerinfolink.net/2011/10/27/are-changes-in-psa-kinetics-potentially-indicative-of-metastasis-free-survival/2011-10-27T20:43:16+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/27/14267/2011-10-27T12:40:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/26/psa-screening-today-four-points-of-view-in-the-nejm/2011-10-28T12:30:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/26/screening-saved-my-life-just-how-accurate-is-that-claim/2011-10-28T21:47:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/26/what-happens-next-after-a-baseline-psa-test/2011-10-27T11:26:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/24/major-new-cancer-clinical-and-genetic-database-to-be-built-in-boston/2011-10-24T18:45:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/23/another-investigational-test-may-refine-data-on-need-for-porostate-biopsy/2011-10-31T20:07:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/22/quality-of-life-after-initial-watchful-waiting-compared-to-immediate-treatment/2011-10-23T03:01:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/20/3-tesla-mri-imaging-and-the-diagnosis-of-localized-prostate-cancer/2012-02-04T21:32:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/19/14218/2011-10-20T14:56:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/18/can-sebelius-actually-not-cover-the-costs-of-psa-testing-for-medicare-patients/2011-10-26T21:50:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/17/another-separate-look-at-the-value-of-mass-psa-based-screening/2011-10-26T12:54:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/17/prostatak-theragene-and-the-evolution-of-vaccine-like-therapies-for-prostate-cancer/2011-10-17T16:16:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/16/another-eminent-urologic-oncologist-on-the-uspstf-recommendation/2011-10-17T10:55:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/16/metformin-in-the-management-of-adt-related-side-effects-and-morbidities/2011-10-16T09:58:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/15/one-expert-clinicians-very-public-opinion-about-ther-uspstf-recommendation/2011-10-29T00:47:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/10/irx4204-enters-phase-ii-clinical-trials-in-men-with-crpc/2011-10-15T11:40:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/14/abiraterone-or-mdv3100-which-might-win-the-coming-conflict/2011-10-15T17:21:58+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/14/opinions-on-the-uspstf-recommendation-are-all-over-the-map-and-all-off-the-money/2011-10-18T22:48:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/13/another-breakthrough-in-prostate-cancer-research-hmmm/2011-10-15T11:38:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/12/the-uspstf-recommendation-how-to-comment/2011-10-20T03:07:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/10/is-surgery-appropriate-for-men-with-high-risk-prostate-cancer/2012-02-07T07:27:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/10/uspstf-and-psa-testing-in-media/2011-10-13T01:01:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/10/pcf-responds-to-uspstf-recommendation-about-psa-screening/2012-01-27T20:31:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/09/the-uspstf-on-implementation-of-their-recommendation/2011-10-10T04:05:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/08/poor-science-underlies-the-uspstf-recommendation-about-psa-based-screening/2011-10-10T19:06:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/07/uspstf-forced-to-release-psa-recommendations-earlier-than-expected/2011-10-12T10:38:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/06/dr-howard-scher-on-circulating-t-cells/2011-10-06T22:08:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/05/14099/2011-10-06T21:45:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/06/expert-commentary-on-new-drugs-for-mcrpc/2011-10-06T21:44:24+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/06/uspstf-advises-against-all-psa-screening-in-healthy-men/2011-10-08T02:45:02+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/23/a-patient-centric-approach-to-the-discussion-about-testing-for-prostate-cancer-risk/2011-10-06T11:56:21+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/05/to-screen-or-not-to-screen-that-is-the-question/2011-10-07T17:05:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/05/sex-after-rp-its-out-there-on-the-radio/2011-10-05T14:59:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/04/excess-deaths-among-some-older-men-with-prostate-cancer/2011-10-08T20:07:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/04/more-data-needed-on-prostate-cancer-and-men-from-specific-ethnic-groups/2011-10-04T12:34:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/03/does-eribulin-mesylate-have-potential-in-mcrpc-or-not/2011-10-03T17:27:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/02/registry-initiative-now-holds-data-on-500-cyberknife-patients/2011-10-04T16:31:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/30/eggs-prostate-cancer-and-the-daily-mail/2011-10-07T04:36:16+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/30/uks-national-health-service-will-not-pay-for-cabazitaxel-in-mcrpc-at-the-proposed-price/2011-10-02T13:34:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/01/new-options-after-standard-hormone-therapy-has-failed/2012-02-03T21:06:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/10/01/selenium-in-treatment-of-men-with-hg-pin-to-prevent-prostate-cancer/2011-10-01T05:03:49+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/30/the-personalization-of-prostate-cancer-management-a-way-to-go-yet/2011-09-30T19:14:38+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/17/an-important-opportunity-for-newly-diagnosed-untreated-patients/2012-01-26T13:17:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/28/long-term-watchful-waiting-and-quality-of-life-outcomes-compared-to-immediate-treatment/2012-01-14T11:50:33+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/28/saw-palmetto-extract-does-not-shrink-prostate-size-redux/2011-09-29T18:55:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/27/how-much-hypofractionated-imrt-is-too-much-for-localized-prostate-cancer/2011-09-27T22:31:09+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/27/new-data-on-the-genetics-of-aggressive-prostate-cancer-but/2011-09-27T13:45:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/26/abiraterone-acetate-treatment-affects-fatigue-in-men-with-mcrpc/2011-10-05T06:17:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/26/28-year-risk-for-prostate-cancer-in-copenhagen-based-on-baseline-psa-data/2011-10-05T15:25:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/26/ibandronate-for-relief-of-pain-in-men-with-metastatic-prostate-cacner/2011-09-26T13:38:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/26/full-data-report-from-the-alsympca-trial-of-radium-223-presented/2011-09-26T11:59:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/24/the-economics-of-prostate-cancer-in-the-western-world/2011-09-24T22:44:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/23/u-s-fda-approves-nadia-prosvue-prognostic-test-for-prostate-cancer/2011-09-24T01:59:45+00:00monthlyhttp://prostatecancerinfolink.net/site-map/about/sab/2011-09-23T14:15:43+00:00weekly0.6http://prostatecancerinfolink.net/2011/09/23/new-data-on-risks-of-prostate-biopsy-and-prostate-cancer-diagnosis-follow-up/2011-09-23T17:38:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/22/predicting-sexual-function-after-first-line-treatment-for-prostate-cancer/2011-09-25T17:16:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/06/educating-the-family-doctor-about-prostate-cancer-management/2011-09-21T21:49:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/21/new-acr-appropriateness-criteria%c2%ae-for-locally-advanced-high-risk-prostate-cancer/2011-09-21T12:33:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/21/j-r-pitt-hyde-and-the-development-of-gtx/2011-09-21T11:54:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/20/calypsos-rt-targeting-technology-to-be-acquired-by-varian/2011-09-20T19:55:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/20/before-prostate-cancer-too-goes-down-the-same-road-to-hell/2011-09-22T17:23:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/19/beyond-the-abstract-treatment-options-for-localized-prostate-cancer/2011-09-21T13:43:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/19/oncogenex-makes-saturn-trial-of-custirsen-ogx-011-more-accessible/2011-09-19T18:31:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/19/fda-expands-approval-of-denosumab-in-men-with-advanced-prostate-cacner/2011-09-19T18:28:54+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/19/intraoperative-tumor-specific-fluorescence-imaging-will-it-work-in-prostate-cancer/2011-09-19T14:16:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/16/prostate-cancer-sunday-lunch-at-the-white-house/2011-09-19T11:17:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/18/how-many-current-psa-detected-localized-prostate-cancers-are-really-appropriate-for-focal-therapy/2011-09-21T13:22:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/17/all-the-different-types-of-external-beam-radiation-therapy-for-prostate-cancer-a-good-introduction/2011-09-21T10:14:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/16/if-aezs-108-works-in-endometrial-cancer-will-it-work-in-prostate-cancer-too/2011-09-16T15:27:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/13/de-gerry-chodak-on-live-with-dr-sandy/2011-09-15T18:46:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/15/show-me-the-proton-beam-radiation-therapy-data/2011-09-18T03:32:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/15/ge-heads-up-1-billion-cancer-detection-and-treatment-plan/2011-09-22T20:22:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/15/adjuvant-radiation-adt-after-surgery-for-sv-prostate-cancer/2011-10-18T02:55:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/13/what-fda-drug-approval-does-and-does-not-mean/2011-09-17T11:55:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/13/the-man-who-wishes-hed-never-had-the-psa-test-he-demanded/2011-09-18T15:55:53+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/12/an-introduction-to-the-concept-of-intermittent-adt/2011-09-13T12:47:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/12/oncothyreon-enrolls-first-patient-in-phase-ii-trial-of-px-866-for-crpc/2011-09-12T16:50:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/12/bisphosphonates-in-management-of-osteoporosis-an-fda-update/2011-09-12T13:54:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/09/what-does-your-doctor-mean-by-localized-prostate-cancer/2011-09-11T14:55:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/08/new-decision-aid-for-men-with-clinically-localized-prostate-cancer/2011-09-08T20:45:16+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/08/canadian-company-claims-new-test-is-600-more-accurate-than-free-psa-test/2011-09-08T18:36:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/07/another-update-on-cabozantinib-xl184/2011-09-08T13:26:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/07/european-commission-approves-abiraterone-acetate-for-mcrpc/2011-09-07T18:52:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/07/clinical-depression-among-prostate-cancer-patients-a-10-year-analysis/2011-09-07T18:14:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/06/what-did-the-doctor-actually-tell-you-about-your-prostate-cancer/2011-09-08T05:39:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/02/jx-594-and-prostate-cancer-some-follow-up/2011-09-12T19:55:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/03/lets-hear-it-for-the-broccoli-and-the-brussels-sprouts/2011-10-20T21:03:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/02/more-good-reasons-to-stop-smoking-if-you-are-at-risk-for-prostate-cancer/2011-09-03T23:51:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/01/might-jx-594-have-significant-clinical-activity-in-prostate-cancer/2011-09-01T21:17:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/09/01/but-does-it-make-a-blind-bit-of-difference/2011-09-01T16:20:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/31/the-gradual-acceptance-of-active-surveillance-in-prostate-cancer-management/2011-09-06T14:55:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/31/adamis-initiates-phase-iiia-trial-of-apc-100/2011-08-31T15:27:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/30/fda-advisory-board-to-review-gen-probes-pca3-test-next-year/2011-08-30T20:00:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/14/psychiatric-treatment-among-swedish-men-with-prostate-cancer/2011-08-30T18:59:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/30/should-all-low-risk-prostate-cancer-patients-be-re-biopsied-prior-to-implementation-of-active-surveillance/2011-08-31T15:54:06+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/30/prostate-cancer-mortality-rates-in-denmark-1998-to-2009/2011-09-07T18:26:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/29/post-surgical-enrollment-in-clinical-trials-by-cancer-patients/2011-08-30T03:38:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/29/bone-mineral-density-and-other-risk-factors-for-fractures-in-men-on-adt/2011-09-01T01:37:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/27/positive-surgical-margins-systemic-disease-and-prostate-cancer-specific-mortality/2011-08-30T02:26:21+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/27/urotoday-offers-major-discount-for-patients-and-consumers/2011-09-06T00:01:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/26/a-new-way-to-look-at-side-effects-of-first-line-prostate-cancer-treatment/2011-08-29T11:11:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/25/the-role-of-radical-prostatectomy-in-older-males-with-high-risk-prostate-cancer/2011-08-26T14:46:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/26/prostate-cancer-care-through-the-uks-national-health-service/2011-08-29T18:04:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/25/whole-ginger-extract-in-prostate-cancer-prevention-and-treatment/2011-08-31T18:37:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/25/manserin-as-possible-marker-of-prostate-cancer-progression/2011-08-25T17:17:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/25/update-on-development-of-cabozantinib-xl184-in-advanced-prostate-cancer/2011-09-18T16:14:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/24/libya-lockerbie-zytiga-and-life/2011-08-25T21:27:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/24/the-proposed-reality-trial-and-the-impact-of-statins-on-prostate-cancer/2011-08-25T11:22:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/22/complementary-and-alternative-medicine-and-prostate-cancer-care/2011-08-24T13:11:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/23/should-all-cribriform-prostate-cancers-be-classified-as-gleason-4-disease/2011-08-25T03:13:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/23/fda-fast-tracks-nda-for-alpharadin-in-mcrpc/2011-08-24T18:01:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/22/approval-of-denosumab-for-extension-of-metastasis-free-survival-in-the-usa/2011-08-22T17:37:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/22/the-fine-art-of-the-circular-argument-applied-to-management-of-prostate-cancer/2011-08-22T15:18:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/22/uk-includes-prostate-cancer-in-new-stratified-medicine-pilot-program/2011-08-22T12:30:16+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/19/low-dose-des-in-the-management-of-crpc/2011-08-19T19:49:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/19/of-genes-snps-association-personalized-medicine-and-prostate-cancer-risk/2011-08-19T19:42:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/18/health-canada-approves-use-of-gen-probe-pca3-test/2011-08-18T17:30:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/17/an-hormonal-storm-in-a-set-of-italian-pre-surgical-teacups/2011-08-17T16:54:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/16/out-on-the-frontiers-of-research-on-the-genetics-of-cancer/2011-08-16T14:13:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/11/new-urine-test-based-may-be-able-to-eliminate-need-for-biopsy-in-many-patients/2011-08-16T10:49:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/16/further-experience-with-salvage-hifu-after-first-line-ebrt/2011-10-17T16:27:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/15/perception-delusion-misinformation-and-consequent-behaviors/2011-08-15T19:09:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/15/is-an-lhrh-antagonist-a-better-first-line-hormone-therapy-than-an-lhrh-agonist/2011-08-15T15:41:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/15/combining-a-tki-with-bicalutamide-in-men-with-crpc/2011-08-15T12:52:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/14/diet-and-prostate-cancer-risk-a-case-control-study-analysis/2011-10-20T20:50:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/12/health-related-qol-after-salvage-hifu-for-recurrent-localized-prostate-cancer/2011-08-12T19:27:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/12/the-new-2date4love-web-service/2011-08-12T17:22:58+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/12/galiellalactone-and-the-inhibition-of-prostate-cancer-stem-cells/2011-08-12T17:11:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/12/does-lapatinib-have-potential-in-early-management-of-progressive-prostate-cancer/2011-08-13T14:29:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/11/risk-stratification-of-men-with-high-risk-prostate-cancer-prior-to-first-line-surgery/2011-08-12T10:50:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/11/long-term-qol-of-men-in-the-scandinavian-prostate-cancer-group-4-clinical-trial/2011-08-11T13:59:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/10/feasibility-of-focal-hifu-a-pilot-study-with-10-year-follow-up-data/2011-08-11T16:18:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/09/height-risk-and-higher-grade-forms-of-prostate-cancer/2011-08-10T22:11:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/09/immediate-adjuvant-therapy-for-men-with-positive-surgical-margins-after-rp/2011-08-09T16:01:06+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/08/can-specific-mirnas-be-used-to-predict-risk-of-early-biochemical-relapse-after-first-line-treatment/2011-08-10T18:08:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/08/ppaca-cancer-disparities-and-health-care-reform/2011-08-08T13:29:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/08/time-related-loss-of-erectile-function-after-low-dose-rate-brachytherapy/2011-08-08T13:06:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/07/5%ce%b1-reductase-iii-and-its-potential-in-preventiontreatment-of-prostate-cancer/2011-08-08T00:56:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/05/incidence-of-climacturia-surprising-to-one-leading-surgeon/2011-09-03T22:49:58+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/04/new-urine-test-combines-data-from-pca3-and-gene-fusion-to-predict-prostate-cancer-risk/2011-08-05T06:56:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/03/do-cancer-and-non-cancer-patients-make-equal-sacrifices-to-pay-for-their-meds/2011-08-03T19:52:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/03/heat-shock-protein-inhibitors-in-crpc-an-update/2011-08-04T13:20:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/03/evidence-based-medicine-and-the-value-of-permanent-seed-brachytherapy/2011-08-04T01:04:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/02/disagreement-over-prostate-cancer-screening-guidelines-in-oz/2011-08-03T04:33:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/02/how-good-are-good-trifecta-data-after-surgery/2011-08-03T14:13:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/01/health-canada-approves-abiraterone-acetate-zytiga/2011-08-01T20:48:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/08/01/dignity-therapy-at-the-end-of-life/2011-08-01T16:16:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/31/of-genetics-diabetes-and-prostate-cancer-risk/2011-07-31T14:25:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/29/of-genes-and-patents-and-myriad-genetics/2011-07-29T18:30:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/29/vitamin-d-supplements-may-increase-prostate-cancer-risk-at-least-among-finnish-smokers/2011-08-04T22:56:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/28/retrospective-cohort-analysis-shows-mortality-benefit-in-prostate-cancer-but-theres-a-big-however/2011-07-29T22:03:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/28/there-is-life-after-yana-and-terry-you-deserve-it/2011-08-04T01:44:44+00:00monthlyhttp://prostatecancerinfolink.net/tips-tools/ex-us-prostate-cancer-web-sites/2011-07-28T19:52:37+00:00weekly0.6http://prostatecancerinfolink.net/2011/07/27/utilization-of-standard-treatments-for-localized-prostate-cancer-by-medicare-beneficiaries/2011-07-27T15:45:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/27/over-diagnosis-and-over-treatment-of-prostate-cancer-definitions-expectations-and-estimations/2011-09-01T15:45:24+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/20/the-2011-summit-to-end-prostate-cancer-in-washington-dc/2011-07-26T13:32:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/26/prostate-cancer-and-prostate-cancer-specific-survival-of-men-from-breast-cancer-prone-families/2011-07-26T13:31:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/25/clinical-and-pathologic-staging-of-localized-prostate-cancer-an-update/2011-07-26T15:59:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/25/emea-approves-abiraterone-acetate-for-treatment-of-mcrpc/2011-07-25T18:40:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/24/are-clinical-benefits-of-ralp-being-over-hyped-to-unsuspecting-prostate-cancer-patients/2011-07-25T15:10:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/22/kegel-exercises-incontinence-training-and-recovery-of-continence-after-rp/2011-08-03T16:19:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/22/top-hospitals-for-cancer-and-for-urology/2011-07-22T21:46:54+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/22/whole-gland-cryoablation-as-first-line-therapy-in-prostate-cancer-patients-75-years-of-age/2011-07-25T02:50:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/22/better-defining-appropriate-candidates-for-active-surveillance/2011-07-27T02:59:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/21/safeway-raises-10-million-for-prostate-cancer-research-in-june/2011-07-21T14:19:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/20/lycopene-and-prostate-cancer-prevention-in-african-american-men/2011-07-20T19:08:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/20/aua-comments-on-fda-guidance-on-safe-use-of-5-aris/2011-07-20T19:35:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/20/variation-in-the-informational-needs-of-men-with-localized-prostate-cancer/2011-07-20T13:19:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/20/frequency-of-psa-testing-and-immediacy-of-prostate-cancer-treatment-among-men-over-70/2011-07-20T21:20:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/19/impact-of-adt-on-all-cause-mortality-in-men-treated-with-brachytherapy-based-radiation-therapy/2011-07-20T11:53:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/18/ved-taldalafil-helps-with-return-of-erectile-function-post-surgery-vs-taldalafil-alone/2011-07-18T19:38:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/18/apical-prostate-cancer-and-recurrence-after-hifu/2011-07-21T12:17:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/18/carboplatin-etopside-in-mcrpc-high-toxicity-and-low-efficacy/2011-07-18T12:24:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/18/denosumab-approved-in-europe-for-treatment-of-sres/2011-07-18T10:54:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/15/can-ctc-levels-predict-progression-of-hormone-sensitive-prostate-cancer/2011-07-16T16:40:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/15/prostate-cancer-risk-calculators-and-the-decision-to-have-a-prostate-biopsy/2011-07-15T13:04:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/14/results-of-rtog-94-08-finally-published-in-nejm/2011-07-14T18:58:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/14/subspecialization-and-the-management-of-advanced-prostate-cancer/2011-07-15T02:20:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/14/prostate-cancer-bph-risk-association-and-a-3-million-man-study/2011-07-14T12:29:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/13/should-the-dre-really-be-optional-today/2011-07-14T03:24:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/13/climacturia-as-a-side-effect-of-radical-prostatectomy/2011-07-13T11:11:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/12/proton-beam-radiation-therapy-in-prostate-cancer/2011-08-21T15:25:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/11/race-and-outcomes-after-prostate-brachytherapy/2011-07-11T12:45:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/07/regereron-to-continue-venice-trial-of-aflibercept/2011-08-24T12:07:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/07/medicaid-patients-do-get-better-health-care-than-americas-uninsured/2011-07-20T00:22:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/07/current-status-of-proposed-funding-for-the-dod-pcrp-in-fy-2012/2011-07-07T15:56:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/07/psa-testing-prostate-cancer-mortality-and-an-update-from-the-tyrol/2011-07-08T15:39:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/07/low-risk-prostate-cancer-active-surveillance-and-perineural-invasion/2011-07-07T13:58:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/06/quality-of-life-quality-of-death-and-end-of-life-care/2011-07-07T12:25:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/05/risk-factors-for-vertebral-fractures-among-men-on-adt/2011-07-06T01:07:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/05/13420/2011-07-11T03:22:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/04/at-least-in-ontario-its-not-about-where-you-have-your-surgery/2011-08-03T16:23:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/04/recovery-of-serum-t-levels-after-short-term-lhrh-agonist-therapy/2011-07-05T00:02:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/03/patients-decisions-patients-expectations-and-surgery-for-localized-prostate-cancer/2011-07-05T10:52:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/01/an-interesting-signal-from-cms-as-the-good-guy/2011-07-01T13:07:43+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/01/prostate-cancer-dating-and-the-inevitable-conversation/2011-07-01T11:53:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/07/01/toxic-side-effects-of-adjuvant-salvage-imrt-post-surgery/2011-07-02T02:14:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/26/please-help-us-to-publicize-this-site/2011-07-01T03:44:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/29/capra-s-scores-and-projection-of-prostate-cancer-recurrence-post-surgery/2011-06-30T15:38:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/30/mortality-and-management-of-locally-advanced-prostate-cancer-with-non-curative-intent/2011-07-06T14:43:24+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/30/outcomes-after-surgery-for-spinal-cord-compression-among-men-with-metastatic-prostate-cancer/2011-06-30T11:58:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/30/targeting-the-5%ce%b1-reductase-enzyme-in-treatment-of-prostate-cancer/2011-07-01T02:30:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/29/eating-whole-grain-products-doesnt-reduce-risk-for-prostate-cancer/2011-06-30T08:58:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/29/can-ultrasensitive-psa-at-3-years-post-surgery-project-delayed-bcr/2011-09-13T14:51:58+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/27/surprise-being-married-improves-prostate-cancer-survival/2011-06-28T20:02:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/28/andy-pollack-on-new-prostate-cancer-treatments-in-the-new-york-times/2011-06-28T12:31:53+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/28/amgen-requests-expanded-indication-for-denosumab/2011-06-28T12:17:03+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/22/impact-of-denosumab-on-bone-metastasis-free-survival/2011-06-28T12:12:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/28/ctcs-from-patients-with-crpc-have-specialized-markers/2011-06-28T11:10:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/27/the-role-of-exercise-in-prostate-cancer-management/2011-06-28T11:59:09+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/27/nih-to-run-state-of-the-science-conference-on-active-surveillance/2011-06-27T12:32:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/26/r-i-p-the-demise-of-google-health/2011-06-26T11:23:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/25/prostate-cancer-specific-mortality-rate-dropping-in-france/2011-06-26T02:33:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/24/expanding-understanding-about-african-ancestry-and-prostate-cancer-risk/2011-06-24T14:39:09+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/24/bone-scan-flare-associated-with-treatment-with-abiraterone-acetate/2011-09-05T20:28:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/23/the-psa-screening-debate-its-not-going-away-but/2011-06-24T23:51:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/23/can-common-sage-extract-reduce-frequency-intensity-of-hot-flashes/2011-06-24T00:14:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/23/psa-monitoring-after-prostate-cancer-surgery-how-long-is-long-enough/2011-06-24T17:08:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/23/new-phase-iii-trial-of-gene-suicide-therapy-in-localized-prostate-cancer/2011-06-22T18:52:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/22/men-should-stop-smoking-10-years-before-a-prostate-cancer-diagnosis/2011-09-25T05:13:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/21/a-current-review-of-the-side-effects-of-radical-prostatectomy/2011-06-22T13:57:19+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/01/follow-up-psa-testing-after-surgery-for-low-risk-prostate-cancer/2011-06-21T15:26:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/21/gtx-initiates-phase-iib-trial-of-capesaris-for-advanced-prostate-cancer/2011-06-21T11:48:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/20/new-vaccine-supposedly-cures-prostate-cancer-in-mice/2011-07-08T16:09:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/20/new-imaging-technologies-and-management-of-crpc/2011-06-20T12:44:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/17/acs-projects-33000-prostate-cancer-deaths-in-us-in-2011/2011-06-20T19:20:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/16/fda-does-a-pretty-good-job-of-approving-new-drugs-to-treat-cancer/2011-06-16T15:12:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/16/funding-for-the-dod-pcrp-in-fy-2012/2011-06-20T18:12:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/16/fda-publishes-analysis-of-decision-not-to-approve-5-aris-for-prostate-cancer-prevention/2011-06-19T13:42:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/10/last-call-to-action-time-to-light-the-white-house-blue/2011-06-15T19:55:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/15/so-much-for-a-49-prostate-cancer-mortality-rate-in-the-uk/2011-06-18T15:39:09+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/15/a-49-prostate-cancer-specific-mortality-rate-in-the-uk/2011-06-22T16:16:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/15/the-prostate-act-of-2011/2011-06-15T12:34:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/14/duloxetine-in-treatment-of-mild-to-moderate-post-surgical-incontinence/2011-06-14T21:22:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/14/development-if-new-immunotherapeutic-agents-for-cancer-treatment/2011-06-15T02:48:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/13/is-radiation-therapy-any-better-that-active-surveillance-for-loocalized-prostate-cancer/2011-06-13T15:41:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/13/large-study-to-investigate-mri-prior-to-biopsy-for-prostate-cancer-diagnosis/2011-06-14T02:14:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/13/what-different-specialists-believe-about-adjuvant-radiation-therapy/2011-08-18T14:30:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/12/prostasomes-another-possible-marker-for-prostate-cancer-aggression/2011-10-20T21:27:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/11/risk-associated-with-rapid-rise-in-psa-immediately-following-hifu/2011-06-14T11:13:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/10/better-characterization-diagnosis-of-insignificant-prostate-cancer/2011-06-10T17:16:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/10/5%ce%b1-reductase-inhibitors-and-risk-for-high-grade-prostate-cancer/2011-07-07T15:21:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/09/the-fda-pharmaceutical-industry-complex/2011-06-09T16:52:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/09/a-three-marker-algorithm-for-projecting-prostate-cancer-risk-need-for-biopsy/2011-06-09T13:21:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/09/a-new-and-better-prostate-cancer-specific-imaging-agent/2011-06-09T12:10:53+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/08/expert-opinions-on-active-surveillance-and-surgery-for-localized-prostate-cancer/2011-06-15T03:11:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/08/fda-approves-phase-iiia-trial-of-apc-100/2011-06-08T19:27:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/08/two-more-nails-in-the-coffin-of-xmrv/2011-06-10T12:49:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/08/age-and-risk-for-incontinence-after-radical-prostatectomy/2011-06-08T11:58:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/07/take-home-messages-about-localized-prostate-cancer-from-the-aua-annual-meeting/2011-06-08T20:14:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/07/how-surgeons-and-patients-think-about-post-surgical-incontinence/2011-06-07T18:51:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/06/the-latest-update-on-xl184-cabozantinib/2011-06-07T12:01:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/07/fda-lifts-hold-on-clinical-development-of-gvax/2011-06-07T11:48:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/06/alpharadin-shows-2-8-month-survival-benefit-in-mcrpc/2011-06-06T20:39:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/06/the-management-of-hot-flashes-for-men-on-adt/2011-06-07T00:44:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/05/survival-and-ctc-data-from-the-abiraterone-acterate-pivotal-trial/2011-06-05T12:58:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/04/gi-toxicity-radiation-therapy-and-androgen-deprivation/2011-06-04T12:12:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/04/preliminary-data-on-itraconazole-in-treatment-of-mcrpc/2011-06-05T01:54:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/03/bloodletting-and-the-management-of-localized-prostate-cancer/2011-06-06T09:20:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/03/dose-escalation-of-sbrt-in-treatment-of-localized-prostate-cancer/2011-06-03T16:54:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/03/perineural-invasion-and-risk-for-progression-in-localized-and-locally-advanced-disease/2011-06-03T15:38:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/02/impact-of-abiraterone-prior-to-chemotherapy-maybe-not-4-years-but/2011-06-06T06:53:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/02/statin-use-prostate-cancer-risk-in-men-having-biopsies/2011-06-09T17:19:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/02/what-is-the-risk-of-not-treating-psa-detected-prostate-cancer/2011-09-12T14:08:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/06/01/prostate-cancer-specific-mortality-after-non-curative-treatment-of-locally-advanced-disease/2011-06-01T15:58:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/31/perception-expectation-risk-screening-and-cancer-reality/2011-05-31T13:45:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/31/additional-5-year-follow-up-data-on-sbrt-for-localized-prostate-cancer/2011-06-01T21:34:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/29/diagnosis-and-management-of-localized-prostate-cancer-the-cleveland-clinic-approach/2011-05-29T17:16:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/27/age-exercise-and-adt-effects-on-health-and-fitness-in-prostate-cancer-patients/2011-05-28T12:55:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/27/the-making-of-a-good-doctor-today/2011-05-27T12:47:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/27/how-finnish-doctors-think-about-prostate-cancer-screening/2011-05-28T14:08:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/26/results-of-abiraterone-acetate-phase-iii-trial-in-todays-nejm/2011-05-26T18:12:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/26/psa-and-the-family-physician/2011-05-26T18:36:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/25/avanafil-shows-benefit-against-ed-in-prostate-cancer-patients-post-surgery/2011-05-25T17:28:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/25/how-young-men-have-thought-about-treatment-options-for-gleason-6-prostate-cancer/2011-05-30T20:39:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/24/new-data-suggests-that-acetaminophen-may-prevent-prostate-cancer/2011-05-25T21:31:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/24/prevalence-of-men-with-differing-stages-of-prostate-cancer-in-the-usa/2011-05-25T01:14:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/24/testosterone-replacement-therapy-in-men-with-low-serum-t-and-untreated-prostate-cancer/2011-05-24T10:26:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/23/the-relative-aggressiveness-of-prostate-cancer-in-black-and-white-patients/2011-05-23T19:03:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/22/can-prolaris-test-accurately-predict-risk-for-prostate-cancer-specific-mortality/2011-05-22T13:47:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/20/two-new-drugs-recommended-for-approval-in-europe/2011-05-20T17:41:16+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/10/adjuvant-adt-after-surgery-in-men-with-high-risk-prostate-cancer/2011-05-20T01:07:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/19/mdv3100-vs-abiratetone-acetate-the-analysts-perspectives/2011-05-21T00:34:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/18/the-initial-results-of-the-pivot-study/2012-02-12T20:16:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/19/for-those-who-like-their-coffee-and-for-those-who-dont/2011-05-21T00:41:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/19/toward-a-rational-strategy-for-prostate-cancer-screening/2011-06-03T17:53:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/17/prostate-cancer-treatment-outcomes-among-gay-men/2011-05-18T11:02:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/16/whats-hot-at-the-aua-annual-meeting-monday-afternoon/2011-05-18T10:59:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/16/whats-hot-at-the-aua-annual-meeting-monday/2011-05-16T17:15:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/08/risk-for-prostate-cancer-among-active-duty-usaf-personnel/2011-05-16T16:47:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/15/whats-hot-at-the-aua-annaul-meeting-sunday-morning/2011-05-15T16:26:34+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/14/whats-hot-at-the-aua-annual-meeting-saturday/2011-05-14T18:51:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/06/antibiotic-resistant-infections-associated-with-prostate-biopsy/2011-07-18T11:26:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/13/mlb-ramps-up-efforts-for-prostate-cancer-awarenessfunding/2011-05-18T21:51:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/13/3d-trus-mri-fusion-based-targeted-biopsy-using-artemis-technology/2011-05-13T12:36:49+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/13/comparative-value-of-two-prostate-cancer-risk-calculators-in-canadian-patients/2011-05-13T10:56:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/12/data-from-pivot-to-be-featured-at-upcoming-aua-annual-meeting/2011-05-12T17:07:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/08/maintenant-en-francais-solidarite-prostate-infolink/2011-05-12T11:52:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/11/projected-dramatic-increase-in-diagnosis-of-prostate-cancer-in-canada/2011-05-12T17:02:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/11/diagnosis-of-bph-not-a-risk-factor-for-prostate-cancer/2011-05-11T19:45:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/11/intermittent-vs-continuous-androgen-deprivation-therapy-expert-comment/2011-05-12T17:07:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/10/ascos-president-blogs-about-value-and-prostate-cancer-care/2011-05-10T18:37:45+00:00monthlyhttp://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/pcpt/2011-05-10T11:15:44+00:00weekly0.6http://prostatecancerinfolink.net/2011/05/10/pcps-opinions-about-psa-testing-and-shared-decision-making/2011-05-10T11:07:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/10/use-of-cam-among-rural-prostate-cancer-patients-in-one-us-state/2011-05-10T18:16:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/09/15-years-of-experience-with-hifu-using-ablatherm-technology/2011-05-09T23:36:54+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/09/can-mvp-help-us-to-understand-the-genetics-of-prostate-cancer/2011-05-09T18:34:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/09/gtx-758-to-enter-phase-iib-clinical-trial/2012-01-20T16:25:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/04/write-your-congressman-or-woman-protect-funding-for-the-pcrp/2011-05-08T15:50:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/07/screening-chemoprevention-in-the-diagnosis-of-clinically-significant-prostate-cancer/2011-05-07T13:48:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/06/final-publication-of-data-from-the-ascent-2-clinical-trial/2011-05-06T15:07:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/06/urotoday-transitions-from-free-to-subscription-service/2011-09-09T03:26:23+00:00monthlyhttp://prostatecancerinfolink.net/treatment/first-line-localized/comparative-data-treatment-early-stage-localized-prostate-cancer/watchful-waiting-vs-radical-surgery-the-scandinavian-trial/2011-05-06T14:47:17+00:00weekly0.6http://prostatecancerinfolink.net/2011/05/05/selenium-vitamin-e-soy-and-prostate-cancer-prevention/2011-05-06T18:01:06+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/05/rp-vs-ww-15-year-outcomes-of-the-scandinavian-trial/2011-05-08T17:35:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/04/prostate-cancer-testing-and-diagnosis-in-the-uk-in-2007/2011-05-05T20:20:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/04/reverse-stage-shift-at-major-tertiary-prostate-cancer-center-since-2000/2011-05-04T11:45:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/03/sbrt-in-treatment-of-isolated-prostate-cancer-specific-metastases-to-bone/2011-05-04T13:58:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/03/can-yk-4-279-stop-prostate-cancer-spread-or-metastasis/2011-05-03T12:28:06+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/02/more-data-suggest-benefit-of-aspirin-after-radiation-for-prostate-cancer/2011-05-02T20:17:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/02/outcomes-after-surgery-as-first-line-treatment-for-men-with-high-risk-prostate-cancer/2011-05-03T11:42:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/02/risk-for-prostate-cancer-specific-and-other-forms-of-mortality-at-15-years-of-follow-up/2011-05-03T12:20:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/05/01/accuracy-of-dce-mri-in-men-with-locally-recurrent-prostate-cancer/2011-05-01T12:34:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/30/erectile-function-motivation-sex-and-satisfaction-post-surgery/2011-04-30T16:23:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/25/where-prostate-cancer-stacks-up-as-a-cause-of-death/2011-04-30T12:55:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/30/wishful-thinking-about-abiraterone-acetate-in-crpc/2011-08-06T00:35:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/29/post-surgical-salvage-radiation-therapy-and-all-cause-patient-mortality/2011-04-29T18:50:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/29/the-long-term-results-of-rtog-98-05-an-innovative-brachytherapy-trial/2011-04-30T16:09:34+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/29/genetics-genomics-and-improvements-in-the-management-of-prostate-cancer/2011-04-29T11:28:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/28/fda-approval-of-abiraterone-some-interesting-notes/2011-06-23T03:36:21+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/28/stop-press-fda-approves-abiraterone-acetate/2011-04-29T01:06:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/28/cancer-research-and-americas-minority-populations/2011-04-28T19:55:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/28/a-matched-case-control-study-of-ebrt-pbrt-vs-brachytherapy/2011-04-30T01:06:16+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/28/longer-screening-intervals-for-men-with-psa-levels-2-ngml/2011-05-02T00:09:32+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/27/ebrt-as-salvage-therapy-for-refractory-or-progressive-prostate-cancer-post-hifu/2011-04-27T21:05:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/27/inguinal-hernia-after-open-radical-retropubic-prostatectomy/2011-04-27T15:09:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/27/but-is-it-safe-and-effective-in-people-as-opposed-to-petri-dishes/2011-04-27T20:25:54+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/27/do-macho-men-risk-dying-young/2011-04-27T20:32:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/26/radiation-therapy-for-men-with-locally-advanced-prostate-cancer-a-meta-analysis/2011-04-26T22:11:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/26/diet-serum-levels-of-fatty-acids-and-risk-for-prostate-cancer/2011-04-28T17:53:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/25/an-update-on-hereditary-and-familial-prostate-cancers/2011-04-26T16:09:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/25/new-data-sound-death-knell-for-atrasentan-in-prostate-cancer/2011-04-25T19:32:21+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/25/fflus-preservation-and-post-surgical-outcomes-after-rp/2011-04-25T13:54:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/25/the-potential-of-focal-therapy-another-assessment/2011-04-25T22:56:24+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/23/the-media-and-the-two-major-prostate-cancer-screening-trials/2011-04-25T20:41:09+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/22/quality-of-life-at-12-months-post-surgery-for-localized-prostate-cancer/2011-04-25T18:09:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/21/12666/2011-04-21T17:53:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/21/the-escape-project-who-gets-early-metastasis-and-why/2011-04-25T22:04:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/18/building-a-stronger-prostate-cancer-community/2011-04-21T12:53:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/20/delayed-follow-up-care-of-men-with-a-high-psa-found-to-be-common/2011-04-20T19:32:06+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/20/on-the-feasibility-of-a-universal-cancer-vaccine-but-first-in-prostate-cancer/2011-04-20T13:01:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/20/trc105-and-clinical-trials-in-mcrpc/2011-04-20T11:41:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/19/prostate-cancer-roundtable-gets-web-site-up-and-running/2011-04-19T21:11:53+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/19/does-a-6-month-delay-in-treatment-increase-risk-for-low-risk-patients/2011-04-19T20:47:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/19/the-practical-clinical-value-of-the-pca3-test/2011-04-19T12:22:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/18/genomic-risk-prostate-cancer-endometrial-cancer-linkage/2011-04-18T20:42:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/18/ipsen-group-to-help-develop-market-tasquinimod-for-mcrpc/2011-04-18T17:45:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/16/psadt-and-the-progression-of-prostate-cancer-in-men-on-iadt/2011-04-17T03:16:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/16/penile-implants-after-prostate-cancer-treatment/2011-04-16T10:59:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/15/so-what-is-the-point-of-screening-for-prostate-cancer/2011-04-25T22:07:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/15/phase-iii-clinical-trial-of-tasquinimod-in-mcrpc/2011-04-15T16:05:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/14/drug-may-double-prostate-cancer-survival-but-when/2011-04-15T02:45:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/13/the-johns-hopkins-active-surveillance-outcomes-data-to-date/2011-04-15T12:49:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/12/the-effectiveness-of-salvage-surgery-for-radiation-recurrent-prostate-cancer/2011-04-12T18:13:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/12/the-new-york-times-on-psa-testing-among-older-americans/2011-04-13T01:31:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/11/post-op-pelvic-anatomy-after-ralp-and-open-surgery/2011-04-13T11:39:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/11/does-a-psa-level-20-ngml-preclude-radical-prostatectomy/2011-04-12T02:45:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/11/parkinsons-disease-utah-and-prostate-cancer-risk/2011-05-14T15:51:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/11/screening-for-prostate-cancer-the-cochrane-review/2011-09-29T09:09:24+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/08/does-your-pcp-encourage-psa-testing-at-your-annual-check-up/2011-04-12T08:51:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/07/does-the-pro-psa-test-have-any-significant-practical-clinical-value/2011-05-08T10:03:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/06/80-drugs-in-development-for-prostate-cancer-says-phrma/2011-04-07T17:13:49+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/07/citn-pcctc-and-early-stage-prostate-cancer-trials/2011-04-07T13:33:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/06/prostate-cancer-hormone-therapy-and-physical-well-being/2011-04-08T01:32:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/06/could-new-test-for-ctscs-help-prostate-cancer-patients/2011-04-06T12:44:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/05/a-sad-manipulation-of-data-to-support-a-point-of-view/2011-04-06T22:07:34+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/05/can-digoxin-help-in-treatment-of-prostate-cancer/2011-04-05T17:49:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/05/12521/2011-04-05T16:41:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/04/over-reaction-to-norrkoping-data-in-new-zealand/2011-04-05T16:33:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/04/phase-ii-trial-of-lapatinib-shows-some-activity-in-crpc/2011-04-04T14:27:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/04/114-candidate-gene-panel-can-detect-nearby-prostate-cancer-in-stromal-prostate-tissue/2011-04-04T13:00:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/01/the-norrkoping-prostate-cancer-screening-trial-with-20-year-follow-up/2011-04-25T21:51:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/04/02/cprit-makes-major-award-for-new-prostate-cancer-drug-research/2011-04-02T10:55:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/31/the-natural-history-of-biochemical-recurrence-after-surgery/2011-03-31T15:23:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/31/cms-proposes-medicare-coverage-for-provenge/2011-03-31T13:35:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/31/12472/2011-04-01T20:03:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/30/prostate-cancer-treatment-in-southwestern-georgia-race-and-a-rural-environment/2011-03-30T12:55:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/29/psa-testing-in-men-over-70-years-of-age-some-perspective/2011-03-31T20:13:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/29/understanding-better-how-genetic-variation-may-affect-prostate-cancer-risk/2011-03-31T11:05:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/28/the-new-finasteride-challenge-study/2011-03-29T03:45:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/28/cisplatin-as-second-line-chemotherapy-for-docetaxel-refractory-prostate-cancer/2011-03-28T14:06:49+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/28/how-to-get-really-bad-investment-advice/2011-03-28T17:45:46+00:00monthlyhttp://prostatecancerinfolink.net/site-map/2011-03-28T12:06:38+00:00weekly0.6http://prostatecancerinfolink.net/diagnosis/2011-03-27T20:12:37+00:00weekly0.6http://prostatecancerinfolink.net/tips-tools/pick-prostate-cancer-specialist/2011-03-27T18:03:44+00:00weekly0.6http://prostatecancerinfolink.net/tips-tools/us-based-prostate-cancer-web-sites/2011-03-27T17:29:25+00:00weekly0.6http://prostatecancerinfolink.net/tips-tools/cancer-cannot/2011-03-27T16:04:07+00:00weekly0.6http://prostatecancerinfolink.net/tips-tools/clinicaltrials/nexcura/2011-03-27T15:54:31+00:00weekly0.6http://prostatecancerinfolink.net/tips-tools/clinicaltrials/centerwatch/2011-03-27T15:44:50+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/pomegranate/2011-03-27T10:57:54+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/risk-prostate-cancer/2011-03-27T10:37:36+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/what-prostate-cancer/2011-03-27T10:29:52+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/2011-03-27T03:34:19+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/psa-long-term-marker-risk-prostate-cancer/2011-03-27T02:59:45+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/other-trials/2011-03-27T02:50:55+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/select/2011-03-27T02:41:06+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/equal-risk/2011-03-27T02:31:20+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/5-aris/2011-03-27T02:28:05+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/phsii/2011-03-27T02:21:58+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/preventing-prostate-cancer-a-video-presentation/2011-03-27T02:17:56+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/reduce/2011-03-27T02:11:50+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/prevention-prostate-cancer/2011-03-27T02:07:25+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/risk-prostate-cancer/vasectomy/2011-03-27T01:57:46+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/risk-prostate-cancer/diet-environment/2011-03-27T01:55:48+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/risk-prostate-cancer/race/2011-03-27T01:53:14+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/risk-prostate-cancer/age/2011-03-27T01:48:46+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/risk-prostate-cancer/genetics/2011-03-27T01:46:36+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/pcpt-prostate-cancer-risk-calculator/2011-03-27T01:33:41+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/sunnybrook-prostate-cancer-risk-calculator/2011-03-27T01:32:38+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/exercise-wellness/2011-03-27T01:24:14+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/risk-in-europe/2011-03-27T01:21:54+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/cancer-is-normal/2011-03-27T01:17:48+00:00weekly0.6http://prostatecancerinfolink.net/risk-prevention/propecia/2011-03-27T01:14:53+00:00weekly0.6http://prostatecancerinfolink.net/questions/ask-amy/2012-02-06T17:29:49+00:00weekly0.6http://prostatecancerinfolink.net/questions/ask-arthur/2011-12-16T03:17:56+00:00weekly0.6http://prostatecancerinfolink.net/2011/03/26/degarelix-as-second-line-adt-in-men-not-responsive-to-lhrh-agonist-therapy/2011-03-28T22:25:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/25/us-fda-approves-ipilimumab/2011-08-17T12:54:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/25/6-months-of-neoadjuvant-adt-doubles-survival-when-given-with-radiation-therapy/2012-02-13T14:59:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/25/the-pros-and-and-cons-of-prostate-cancer-treatment-options/2011-03-26T21:30:06+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/23/12283/2011-03-24T17:15:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/24/european-clinical-trials-register-finally-goes-live/2011-03-24T15:14:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/24/a-slight-decrease-in-the-use-of-psa-testing-since-early-2009/2011-03-24T17:48:06+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/23/gsk-withdraws-applications-to-market-dutasteride-for-prostate-cancer-risk-reduction/2011-03-25T13:02:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/23/statin-therapy-seems-to-improve-outcomes-after-radiation-therapy-for-high-risk-patients/2011-03-24T16:46:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/23/abstracts-for-aua-annual-meeting-now-available-on-line/2011-03-23T12:43:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/22/hifu-as-first-line-therapy-in-intermediate-and-high-risk-patinets/2011-05-28T14:51:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/22/regulatory-approval-for-ipilimumab-getting-close/2011-03-22T22:20:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/21/please-donate-free-prostate-cancer-books-for-the-newly-diagnosed/2011-03-22T15:22:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/17/testosterone-therapy-in-untreated-men-with-prostate-cancer/2011-03-27T15:05:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/21/cabazitaxel-gets-final-approval-for-marketing-in-europe/2011-03-23T19:13:02+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/21/repeat-biopsies-may-or-may-not-be-important-for-patients-on-as-even-when-psa-is-stable/2011-03-22T15:18:04+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/16/its-time-to-badger-congress-yet-again-pretty-please/2011-03-21T11:33:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/19/post-surgical-outcomes-of-men-with-positive-seminal-vesicles-over-time/2011-03-21T11:32:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/19/the-prostate-health-index-actual-utility-still-to-be-defined/2011-03-19T16:42:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/18/a-study-in-media-management-for-prostate-cancer-support-group-leaders/2011-03-18T18:27:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/18/diet-veggies-meal-and-prostate-cancer-progression/2011-03-18T13:48:03+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/16/outcomes-after-hifu-and-prognosis-based-on-post-hifu-psa-nadir-levels/2011-03-18T01:50:24+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/17/a-memo-to-the-board-of-directors-of-the-american-cancer-society/2011-03-18T18:41:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/17/five-prostate-cancer-diagnostics-to-watch/2011-03-17T11:48:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/15/are-we-still-over-treating-older-men-with-localized-prostate-cancer/2011-03-15T20:39:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/15/another-update-on-statins-in-prostate-cancer/2011-03-16T20:16:43+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/15/prevalence-of-prostate-cancer-in-the-u-s-a/2011-03-16T22:20:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/14/one-urologists-opinion-on-the-value-of-high-tech-medicine/2011-03-14T20:33:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/14/follow-up-after-finding-of-atypia-on-initial-prostate-biopsy/2011-08-29T20:27:40+00:00monthlyhttp://prostatecancerinfolink.net/site-map/whats-on-this-site/2011-03-13T16:01:07+00:00weekly0.6http://prostatecancerinfolink.net/2011/03/10/adding-a-tki-to-docetaxel-prednisone-for-men-with-mcrpc/2011-03-13T13:28:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/13/tertiary-gleason-grades-and-consequent-prognostic-risk/2011-03-14T03:11:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/13/building-familial-risk-into-prostate-cancer-testing-decisions/2011-03-13T12:02:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/12/adamis-files-ind-to-initiate-clinical-trials-of-apc-100-in-mcrpc/2011-03-12T18:31:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/11/48-hours-at-the-impact-symposium-in-orlando-part-iii/2011-03-12T04:17:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/11/48-hours-at-the-impact-symposium-in-orlando-part-ii/2011-03-11T17:34:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/11/48-hours-at-the-impact-symposium-in-orlando-part-i/2011-03-12T17:39:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/10/senator-mccain-wants-to-cut-funding-for-prostate-cancer-research-by-80-million/2011-03-16T15:55:34+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/10/low-vitamin-d-levels-prevalent-in-early-stage-prostate-cancer/2011-03-16T08:53:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/09/who-really-needs-a-bone-scan-at-time-of-diagnosis/2011-03-11T14:54:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/08/reporting-quality-of-outcomes-after-first-line-rp-for-localized-prostate-cancer/2011-03-11T01:20:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/07/manufacturer-of-cyberknife-system-to-acquire-tomotherapy-inc-too/2011-03-07T19:53:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/07/production-ramp-up-for-provenge-on-track/2011-03-07T13:43:31+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/07/multi-gene-profiling-can-lower-need-for-prostate-biopsies-but/2011-03-07T13:29:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/04/is-spink1-the-prostate-cancer-equivalent-of-her2/2011-03-07T13:28:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/06/pdgfr-inhibition-accelerates-disease-progression-in-men-with-mcrpc/2011-03-06T19:05:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/05/hifu-as-a-salvage-treatment-option-after-radical-prostatectomy/2011-03-05T12:03:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/05/for-those-who-want-to-learn-more-about-new-treatments-for-crpc/2011-03-05T12:03:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/04/salvage-cryoablation-in-men-with-recurrent-prostate-cancer-after-first-line-radiotherapy/2011-03-04T13:31:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/04/lancet-publishes-data-on-denosumab-in-men-with-mcrpc/2011-03-04T12:55:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/03/barvarian-nordic-announces-new-phase-ii-trial-of-prostvac-in-mcrpc-2/2011-03-04T11:57:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/03/unrealistic-optimism-and-participation-in-early-stage-clinical-trials/2011-03-05T17:05:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/03/an-online-nursing-support-system-for-prostate-and-breast-cancer-patients-in-norway/2011-03-03T21:15:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/03/co-morbidity-age-mortality-and-early-stage-prostate-cancer/2011-03-03T13:33:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/02/understanding-the-risk-based-approach-to-prostate-biopsy/2011-03-02T20:05:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/02/vitamins-supplements-and-prostate-cancer-related-risk/2011-03-02T14:45:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/02/another-possible-urine-test-for-detection-of-prostate-cancer/2011-04-01T10:35:03+00:00monthlyhttp://prostatecancerinfolink.net/site-map/about/how-is-this-service-financed/2011-03-02T12:42:53+00:00weekly0.6http://prostatecancerinfolink.net/2011/03/01/vitamin-d-cancer-prevention-research-data-and-media-releases/2011-03-02T03:26:58+00:00monthlyhttp://prostatecancerinfolink.net/2011/03/01/was-prostate-cancer-really-the-cause-of-death/2011-03-03T23:16:40+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/27/psa-velocity-is-it-really-an-appropriate-indicator-for-prostate-biopsy-or-not/2011-11-10T11:25:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/27/agendaabstracts-for-impact-meeting-available-on-line/2011-02-28T02:17:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/26/data-on-acceptanceoutcomes-of-as-regardless-of-age/2011-03-01T23:16:14+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/26/small-decrease-in-psa-testing-at-some-va-medical-centers/2011-02-26T13:52:43+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/25/psa-velocity-and-prostate-cancer-biopsy-guidelines/2011-02-25T13:29:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/24/where-you-live-affects-your-prostate-cancer-treatment/2011-02-24T21:52:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/24/the-coming-realities-in-the-management-of-prostate-cancer/2011-02-25T16:05:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/23/partner-participation-in-prostate-cancer-treatment-decision-making/2011-02-23T14:04:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/23/a-reversal-in-stage-migration-at-one-german-specialty-center/2011-02-23T12:44:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/22/treatment-decision-regret-after-radical-prostatectomy/2011-02-22T16:49:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/21/focal-hemiablative-hifu-in-the-treatment-of-localized-prostate-cancer/2011-11-30T19:48:55+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/21/does-switching-lhrh-agonists-have-a-real-clinical-benefit/2011-02-22T09:10:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/20/over-and-under-imaging-of-newly-diagnosed-prostate-cancer-patients/2011-02-21T02:45:32+00:00monthlyhttp://prostatecancerinfolink.net/2008/12/25/life-exectancy-charlson-score-and-outcomes-in-t3a-prostate-cancer/2011-02-20T16:00:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/19/whats-in-the-future-pipeline-for-treatment-of-mcrpc/2011-02-21T18:32:12+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/18/does-prosvue-accurately-identify-men-at-minimal-risk-for-disease-progression/2011-02-19T11:19:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/18/tasquinimod-ipilimumab-and-cabozatinib-xl184-an-update/2011-05-19T16:31:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/18/a-last-word-from-the-genitourinary-cancers-symposium/2011-02-19T03:27:49+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/18/chemohormonal-therapy-for-metastatic-hormone-naive-prostate-cancer/2011-02-18T16:23:33+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/17/4-and-5-year-outcomes-after-sbrt-for-localized-prostate-cancer/2011-03-18T03:23:22+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/17/experience-certainly-improves-technical-skill-at-ralp/2011-02-18T01:17:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/17/long-term-qol-outcomes-4-years-after-pbrt/2011-02-18T01:10:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/16/the-short-term-potential-future-of-prostate-cancer-prevention/2011-02-17T00:32:44+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/16/does-going-bald-young-increase-your-risk-for-prostate-cancer/2011-02-19T17:05:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/15/its-time-to-invest-in-pomegranate-stocks-or-orchards/2011-02-16T03:03:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/15/intermittent-adt-non-inferior-to-continuous-adt-in-randomized-phase-iii-trial/2011-02-16T02:20:37+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/15/dutasteride-delays-progression-of-prostate-cancer-in-redeem-trial/2011-03-18T00:04:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/15/cancer-management-guidelines-are-exactly-that-guidelines/2011-02-17T22:42:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/14/11860/2011-02-14T13:11:26+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/13/truth-in-screening-how-many-men-to-screen-and-treat-to-save-a-life/2011-02-14T12:17:03+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/13/5-aris-active-surveillance-and-prostate-cancer-progression/2011-02-15T02:44:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/11/the-vitamin-d-saga-another-data-analysis/2011-02-14T14:02:34+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/10/salvage-cryotherapy-as-second-line-treatment-after-first-line-radiation-therapy/2011-02-11T14:44:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/10/oral-taxane-enters-phase-ii-clinical-trial-for-mcrpc/2011-02-10T14:33:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/09/what-if-we-could-sequence-whole-prostate-cancer-genomes/2011-02-11T16:43:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/09/is-ccp-testing-really-the-prognostic-tool-we-need/2011-02-09T15:06:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/05/major-league-sports-and-prostate-cancer-a-challenge/2011-02-08T18:35:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/08/ixmp-as-second-or-third-line-chemotherapy-for-mcrpc/2011-02-09T19:39:56+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/07/outcomes-following-ebrt-and-an-sbrt-boost-for-localized-prostate-cancer/2011-02-07T17:25:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/07/astrazeneca-stops-second-trial-of-zibotentan/2011-02-07T13:47:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/06/limited-value-of-immediate-adjuvant-adt-in-men-with-pt3b-prostate-cancer/2011-02-09T22:36:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/04/most-prostate-cancers-arent-rare-diseases-but-some-are/2011-02-04T12:45:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/04/androgen-supplementation-and-risk-for-prostate-cancer/2011-02-04T12:37:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/03/the-appropriate-selection-of-patients-for-active-surveillance/2011-02-04T17:52:35+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/02/researchers-claim-four-gene-panel-can-identify-high-risk-prostate-cancer/2011-02-06T11:10:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/02/acs-projects-annual-incidence-mortality-data-among-african-americans/2011-02-02T14:51:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/02/french-government-implements-special-reimbursement-policy-for-hifu/2011-02-03T03:37:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/01/pre-surgical-stress-management-and-radical-prostatectomy/2011-03-11T01:40:36+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/01/prostate-cancer-roundtable-announces-revised-policy-agenda/2011-03-27T18:50:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/02/01/perhaps-all-too-much-fus-about-something/2011-02-01T18:12:50+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/30/when-ethics-trump-science-you-need-to-find-a-work-around/2011-01-30T15:48:03+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/27/fda-says-no-to-dutasteride-for-prostate-cancer-prevention/2011-01-28T23:24:47+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/26/the-prognostic-significance-of-perineural-invasion-redux/2011-01-26T19:43:33+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/25/asco-issues-guidance-on-end-of-life-care-for-cancer-patients/2011-02-05T22:25:58+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/24/the-mskcc-malmo-four-kallikrein-model-for-prediction-of-prostate-cancer-risk/2011-01-25T16:28:08+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/24/what-is-the-future-potential-of-abiraterone-acetate/2012-01-05T12:27:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/25/how-abiraterone-acetate-actually-works-in-advanced-prostate-cancer/2011-03-12T17:44:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/23/comorbidity-treatment-and-mortality-among-swedish-prostate-cancer-patients/2011-01-23T19:14:24+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/22/salvage-surgery-as-second-line-therapy-after-hifu-for-localized-prostate-cancer/2011-01-23T00:03:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/22/hrqol-and-the-spirit-trial/2011-01-22T20:00:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/21/so-what-is-the-cell-of-origin-of-prostate-cancer/2011-01-22T01:40:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/21/european-medicines-agency-approves-cabazitaxel/2011-01-21T19:19:01+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/21/projection-of-15-year-prostate-cancer-specific-survival-after-radical-prostatectomy/2012-01-17T09:57:59+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/20/is-ed-a-cause-of-depression-in-prostate-cancer-patients/2011-01-22T03:41:30+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/20/re-thinking-the-application-of-hormone-therapy/2011-02-06T11:44:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/19/pelvic-lymph-node-dissection-and-prostate-cancer-specific-survival-after-surgery/2011-01-20T08:03:15+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/19/could-ssris-be-used-to-manage-hot-flashes-in-men-on-adt/2011-01-20T15:02:20+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/19/third-study-confirms-value-of-psadt-as-a-prognostic-indicator-post-surgery/2011-01-20T06:48:43+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/19/micrornas-mice-and-mirna-therapeutics/2011-01-19T12:50:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/18/the-free-psa-test-in-prostate-cancer-risk-assessment-an-update/2011-12-21T17:03:27+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/17/health-life-expectancy-and-management-choices-for-men-with-localized-prostate-cancer/2011-01-17T14:40:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/17/a-diet-and-exercise-tool-kit-for-patients-on-adt/2011-01-17T14:17:38+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/15/evolving-best-practices-in-the-application-of-active-surveillance/2011-01-17T01:50:17+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/14/five-questions-one-newly-diagnosed-patient-wanted-answers-to/2011-01-15T15:09:05+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/14/finally-why-psa-levels-reflect-prostate-cancer-progression/2011-01-14T20:05:29+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/14/high-grade-pin-and-risk-for-clinically-significant-prostate-cancer-an-update/2011-10-05T21:07:13+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/14/epigenetics-and-prostate-cancer-revisited/2011-01-14T12:15:42+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/13/complementary-and-alternative-medicine-and-newly-diagnosed-prostate-cancer/2011-01-13T14:01:43+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/13/so-kegel-exercises-really-do-work-albeit-a-little-late/2011-01-13T13:41:57+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/13/primary-signet-ring-cell-cancer-of-the-prostate/2011-01-13T13:33:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/12/chromosome-catastrophe-theory-an-introduction-to-chromothripsis/2011-01-12T15:15:41+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/12/more-from-the-european-comparative-effectiveness-research-front/2011-01-12T12:56:53+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/12/5-year-data-on-treatment-of-low-risk-patients-with-sbrt/2011-01-13T11:08:19+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/12/first-androgen-receptor-mrna-antagonist-enters-clinical-trials-for-crpc/2011-01-12T11:28:00+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/11/age-and-co-morbidity-as-risk-factors-for-over-treatment-of-low-risk-prostate-cancer/2011-01-11T12:28:25+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/11/what-you-believe-may-not-be-good-for-you/2011-01-15T20:21:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/11/impt-a-new-acronym-were-all-going-to-need-to-learn/2011-08-12T23:10:04+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/11/international-survey-on-mens-sexual-activity-post-treatment/2011-03-28T02:16:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/10/penile-length-after-ralp-and-rehab-a-small-single-center-case-series/2011-01-10T14:42:10+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/10/comparative-evaluation-of-open-vs-robot-assisted-surgery-for-localized-prostate-cancer/2011-01-10T14:09:11+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/10/kw-2170-not-sufficiently-active-for-use-in-men-with-crpc/2011-01-10T14:07:51+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/08/a-new-and-balanced-guidebook-to-all-the-possible-options/2011-01-10T21:20:28+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/09/87-percent-of-americans-willing-to-be-tested-for-prostate-cancer-maybe/2011-01-09T17:07:54+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/08/algeta-completes-enrollment-in-phase-iii-trial-of-radium-223-chloride/2011-01-08T13:33:48+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/07/delayed-onset-of-castration-resistance-with-serum-t-based-lhrh-agonist-regimens/2011-01-07T21:04:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/07/social-networking-science-and-prostate-cancer-support/2011-02-02T17:59:18+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/07/does-topography-of-cancer-in-the-prostate-correlate-to-risk-for-positive-lymph-nodes/2011-01-07T12:07:07+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/06/regular-exercise-and-prostate-cancer-specific-survival/2011-01-06T20:38:23+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/06/the-continuing-importance-of-primary-gleason-pattern-4-in-gleason-7-prostate-cancer/2011-01-07T01:53:34+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/05/acr-and-astro-issue-new-guideline-on-brachytherapy/2011-01-06T00:57:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/01/modeling-the-life-expectancy-benefits-of-active-surveillance/2011-01-05T12:38:54+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/04/why-do-some-nutritional-supplements-seem-to-delay-prostate-cancer-progression/2011-01-05T02:44:45+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/04/consumer-reports-on-first-line-management-of-prostate-cancer/2011-01-04T13:36:52+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/03/will-the-fda-be-approving-ipilimumab-relatively-soon/2011-01-03T21:27:46+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/03/new-chip-based-technology-can-isolate-identify-prostate-cancer-cells-in-blood/2011-06-23T17:48:39+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/02/nccn-issues-patient-guidelines-on-prostate-cancer-diagnosis-and-management/2011-01-02T20:26:03+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/02/active-surveillance-gets-a-major-endorsement-in-oz/2011-01-02T14:40:43+00:00monthlyhttp://prostatecancerinfolink.net/2011/01/01/major-expectations-from-the-clinical-research-front-in-2011/2011-01-01T13:53:39+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/31/the-earliest-known-case-of-advanced-metastatic-prostate-cancer/2011-01-03T21:30:17+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/31/additional-data-on-short-term-outcomes-of-pbrt/2010-12-31T12:20:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/26/castrate-serum-t-levels-and-prostate-cancer-specific-mortality/2011-04-06T11:16:47+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/30/nci-takes-first-step-to-re-vamp-clinical-trials-process-in-us/2010-12-30T23:41:01+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/29/second-study-confirms-data-on-psadt-and-survival-post-surgery/2010-12-30T03:21:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/28/does-adt-raise-your-risk-for-cataracts/2010-12-28T14:21:12+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/27/why-men-choose-specific-first-line-types-of-management-for-localized-prostate-cancer/2010-12-29T14:34:41+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/27/side-effects-of-surgery-among-patients-diagnosed-in-the-goteborg-screening-trial/2010-12-29T21:48:33+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/25/5-year-outcomes-data-fro-a-french-series-of-hifu-patients/2010-12-25T11:43:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/23/inflammation-biomarkers-and-risk-for-prostate-cancer/2010-12-23T21:38:12+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/22/interpretation-speculation-and-the-politics-of-prostate-cancer/2010-12-22T15:44:34+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/22/can-we-reduce-adverse-effects-of-adt-through-cyclical-estrogen-therapy/2010-12-22T13:57:41+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/22/adverse-effects-of-first-line-treatments-for-localized-prostate-cancer/2010-12-23T04:17:50+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/21/when-is-localized-prostate-cancer-clinically-insignificant/2010-12-21T13:51:41+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/21/jj-submits-data-for-regulatory-approval-of-abiraterone-acetate/2011-06-07T18:24:02+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/20/does-lifestyle-intervention-affect-prostate-cancer-outcomes/2010-12-20T22:27:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/20/initial-study-of-single-dose-hdr-brachytherapy-for-localized-prostate-cancer/2010-12-20T15:33:54+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/19/prostate-weight-and-risk-for-positive-margins-at-surgery/2010-12-19T12:13:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/19/psa-and-risk-for-prostate-cancer-in-men-taking-dutasteride/2010-12-20T21:34:47+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/18/large-employers-to-launch-multi-year-cancer-in-the-workplace-initiative/2010-12-18T21:48:23+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/18/comparative-effectiveness-research-and-localized-prostate-cancer/2010-12-22T20:25:07+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/17/co-morbidity-and-management-of-the-man-with-low-risk-localized-prostate-cancer/2010-12-17T15:59:47+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/16/mixing-genetic-profiling-with-psa-data-to-project-prostate-cancer-risk/2010-12-17T14:59:11+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/17/the-right-way-to-deliver-palliative-radiation-therapy-for-pain-management/2010-12-17T12:48:23+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/17/variation-of-psa-values-over-time-in-individual-patients/2010-12-17T12:46:45+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/16/diabetes-and-quality-of-life-among-men-with-prostate-cancer/2010-12-16T17:44:35+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/15/age-at-treatment-does-not-appear-to-affect-survival-after-brachytherapy/2010-12-17T21:26:26+00:00monthlyhttp://prostatecancerinfolink.net/2009/11/19/how-to-calculate-and-use-your-capra-score/2010-12-14T22:42:54+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/13/sexual-orientation-and-impact-of-andogen-deprivation-therapy/2010-12-14T13:01:33+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/14/denosumab-delays-onset-of-bone-mets-in-men-with-crpc/2010-12-14T12:52:28+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/13/preliminary-results-of-rtog-96-01-in-progressive-prostate-cancer/2010-12-13T21:40:24+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/13/10-year-outcomes-after-high-dose-imrt-for-localized-prostate-cancer/2010-12-15T14:40:32+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/11/11216/2010-12-13T03:55:17+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/10/consumer-education-about-the-value-of-psa-testing/2010-12-17T23:23:23+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/09/the-management-of-high-and-intermediate-risk-prostate-cancer-in-elderly-males/2010-12-14T22:35:44+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/08/other-prostate-cancer-news-wednesday-december-8-2010/2010-12-10T21:48:42+00:00monthlyhttp://prostatecancerinfolink.net/diagnosis/psa-testing/2010-12-10T15:44:40+00:00weekly0.6http://prostatecancerinfolink.net/2010/12/09/how-often-is-a-psa-test-really-needed-to-identify-risk/2010-12-14T20:58:12+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/09/initial-data-from-genomic-health-test-for-recurrent-or-progressive-prostate-cancer/2010-12-11T16:16:12+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/08/informed-choice-and-the-right-to-appropriate-psa-testing/2010-12-14T20:37:58+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/08/pretreatment-t-level-and-post-surgical-pathologic-stage-a-prognostic-relationship/2010-12-08T21:15:30+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/08/age-treatment-and-outcomes-for-men-with-high-risk-prostate-cancer/2010-12-08T13:43:58+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/07/two-negatives-dont-make-a-positive-in-patients-with-crpc/2010-12-07T16:38:20+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/06/baby-aspirin-cuts-risk-for-prostate-cancer-mortality/2010-12-07T02:13:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/06/uk-national-screening-committee-advises-against-psa-based-screening-initiative/2010-12-07T14:29:48+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/06/incidence-and-mortality-rates-in-37-european-countries/2010-12-07T03:47:32+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/05/unexpected-discovery-of-new-investigational-drug-for-mcrpc/2010-12-05T13:37:55+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/04/its-enough-to-make-a-vegan-cry/2011-11-26T04:26:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/03/bmi-1-in-the-regulation-of-prostate-cancer-development/2010-12-03T20:26:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/02/check-your-finger-lengths-if-you-want-to-but/2010-12-02T17:08:20+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/01/odac-rejects-approval-of-dutasteride-for-prostate-cancer-prevention/2011-04-06T21:17:38+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/01/pca3-psa-and-free-psa-in-prediction-of-prostate-cancer-risk/2010-12-04T06:24:16+00:00monthlyhttp://prostatecancerinfolink.net/2010/12/01/fda-advisory-committee-to-review-dutasteride-as-chemopreventive-agent/2010-12-02T20:32:19+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/29/11070/2010-12-01T11:57:53+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/30/iom-panel-changes-recommendations-for-vitamin-d/2010-11-30T19:13:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/29/the-aggressive-treatment-of-high-risk-prostate-cancer-localized-and-node-positive-prostate-cancer/2010-12-02T01:18:24+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/29/eli-lilly-get-fda-approval-for-under-arm-testosterone-supplement/2010-11-29T16:24:39+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/29/comparative-data-on-open-and-robot-assisted-prostatectomy-in-low-caseload-facilities/2010-11-29T19:31:31+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/27/no-wonder-men-get-confused-about-prostate-cancer/2010-11-30T07:00:46+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/25/15-years-of-experience-from-a-multidisciplinary-prostate-cancer-clinic/2010-11-29T15:25:22+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/26/duloxetine-as-a-possible-treatment-for-post-surgical-incontinence/2010-11-26T11:55:11+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/23/the-2010-prostate-cancer-thanksgiving-report/2010-11-25T20:27:16+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/24/endoglin-can-suppress-human-prostate-cancer-cell-metastasis-at-least-in-mice/2010-11-25T14:05:35+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/22/accuracy-and-relevance-of-clinical-stage-in-diagnosis-and-prognosis-of-localized-prostate-cancer/2010-11-23T02:51:27+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/22/the-world%e2%80%99s-first-annual-men%e2%80%99s-health-night/2010-11-23T18:58:39+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/21/does-xmrv-cause-prostate-cancer-the-controversy-continues/2010-11-23T19:30:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/19/the-rationale-for-a-second-pathological-opinion/2010-11-19T21:38:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/19/us-fda-approves-xgeva-for-prevention-of-skeletal-related-events/2010-11-19T17:23:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/19/if-its-thursday-it-must-be/2010-11-21T01:03:51+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/19/should-we-be-letting-the-sleeping-dogs-lie/2010-11-19T14:06:35+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/18/provenge-wins-favorable-vote-at-cms-hearing/2010-11-18T21:10:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/18/xl184-shows-potential-promise-in-patients-with-mcrpc/2011-09-05T00:50:44+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/18/new-contributor-joins-infolink-team/2010-11-18T12:33:09+00:00monthlyhttp://prostatecancerinfolink.net/diagnosis/newly-diagnosed/2010-11-18T02:36:54+00:00weekly0.6http://prostatecancerinfolink.net/treatment/staging-grading/clinical-staging/2010-11-17T20:33:25+00:00weekly0.6http://prostatecancerinfolink.net/2010/11/17/the-spreading-of-pbrt-centers-across-america/2010-12-06T14:53:14+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/16/new-european-guidelines-on-clinically-localized-prostate-cancer/2010-11-17T13:15:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/16/changing-physicians-behaviors-about-psa-testing/2010-11-19T00:52:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/15/is-pca3-any-more-useful-than-a-psa-test-in-the-real-world/2010-11-15T19:06:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/15/neuropathy-in-the-lower-extremities-after-ralp/2010-11-15T18:41:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/14/on-fatherhood-female-children-and-prostate-cancer-risk/2010-12-02T06:56:28+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/13/prediction-of-20-to-30-year-risk-for-advanced-prostate-cancer/2010-11-18T01:19:17+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/13/an-open-letter-to-the-national-football-league/2010-11-14T20:03:46+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/12/researcher-seeks-help-for-study-on-masculinity-and-prostate-cancer/2010-11-12T14:51:02+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/12/psa-tests-prostate-biopsies-and-the-power-of-circular-thinking/2011-03-06T22:07:06+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/12/a-new-voice-in-the-prostate-cancer-screening-debate/2010-11-12T12:52:44+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/11/colorectal-cancer-among-prostate-cancer-patients-treated-with-adt/2010-11-16T17:05:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/11/full-report-on-the-toremifene-phase-iii-fracture-prevention-trial/2010-11-12T01:03:22+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/11/what-one-hospital-ceo-thinks-about-pbrt/2010-11-11T11:45:48+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/10/i-just-want-to-give-it-my-best-shot-and-the-good-lord-willing/2010-11-12T17:35:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/10/surgical-experience-caseload-and-short-term-complications-at-radical-prostatectomy/2010-11-16T21:51:37+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/10/the-continuing-genistein-saga-all-data-and-no-results/2010-11-10T13:39:44+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/09/risk-for-secondary-cancers-after-first-line-radiation-therapy-for-prostate-cancer/2010-11-10T23:05:35+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/08/an-interestingly-high-level-of-gu-complications-after-pbrt/2010-11-09T03:12:37+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/02/an-unenthusiastic-review-of-hifu-in-prostate-cancer/2010-11-08T17:16:11+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/08/a-possible-chemotherapy-for-small-cell-carcinoma-of-the-prostate/2011-02-27T23:06:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/08/the-potential-of-the-prostate-cancer-stem-cell/2010-11-08T11:59:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/07/dedicated-prostate-cancer-specific-virtual-biobank-launched-in-uk/2010-11-07T14:26:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/07/serum-t-and-extended-survival-on-adt-upgrading/2010-11-07T13:25:30+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/06/refining-the-potential-genetic-component-of-prostate-cancer-risk/2010-11-06T14:53:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/05/weight-wait-dont-tell-us-what-we-dont-want-to-hear/2010-11-07T02:15:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/05/could-having-a-diagnosis-of-localized-prostate-cancer-increase-life-expectancy/2010-11-16T03:31:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/05/what-does-a-real-cancer-screening-benefit-need-to-look-like/2010-11-08T02:29:56+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/04/prostate-cancer-specific-mortality-after-biochemical-recurrence-in-a-cohort-of-us-veterans/2011-03-22T17:45:28+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/04/tak-700-to-start-phase-iii-clinical-trial-in-mcrpc/2011-07-24T14:08:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/04/rats-to-you-a-critical-adt-research-finding/2010-11-05T04:54:56+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/04/changes-in-use-of-lhrh-agonists-between-2003-and-2005-and-related-matters/2010-11-07T02:17:28+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/03/adverse-effects-of-adt-in-men-with-non-metastatic-prostate-cancer/2010-11-04T18:13:44+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/03/cancer-screening-and-informed-patient-decision-making/2010-11-04T02:56:06+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/02/re-analysis-of-data-from-the-pclo-screening-study-what-is-truth/2010-11-05T02:31:25+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/01/10-year-follow-up-of-brachytherapy-plus-in-high-risk-localized-prostate-cancer/2010-11-02T11:21:31+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/01/vital-says-nsaids-not-effective-in-prostate-cancer-prevention/2010-11-01T16:53:39+00:00monthlyhttp://prostatecancerinfolink.net/2010/11/01/language-masculinity-and-prostate-cancer-therapy-a-social-perspective/2010-11-04T03:28:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/31/evaluating-the-need-for-immediate-adjuvant-radiation-therapy-after-surgery/2010-10-31T13:07:22+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/25/approval-of-dutasteride-for-reduction-in-risk-for-prostate-cancer/2010-10-30T18:49:43+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/30/15-year-outcomes-after-brachytherapy-for-localized-prostate-cancer/2010-11-01T13:33:00+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/30/the-over-use-of-imaging-studies-in-low-risk-prostate-cancer-patients/2010-11-01T13:49:36+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/29/fewer-lymph-node-dissections-and-fewer-positive-lymph-nodes-does-it-actually-matter/2010-10-30T03:06:50+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/29/adverse-toxicities-of-high-dose-pbrt-a-phase-ii-clinical-trial/2010-10-30T18:34:34+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/29/slightly-fewer-severe-complications-after-imrt-compared-to-crt/2010-10-29T11:27:08+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/27/does-taking-aspirin-really-reduce-risk-for-prostate-cancer-specific-mortality/2010-10-28T19:57:58+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/28/psa-testing-seems-to-lower-long-term-risk-for-prostate-cancer-metastasis/2010-10-29T23:21:26+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/27/adt-radiation-vs-adt-alone-in-men-with-high-risk-localized-prostate-cancer/2010-10-28T19:53:55+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/28/what-to-make-of-a-very-high-pca3-test-result/2012-01-22T03:06:42+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/28/soy-isoflavones-and-radiation-therapy-a-pilot-study/2011-01-01T16:52:26+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/27/serum-alkaline-phosphatase-levels-and-and-survival-of-patients-with-mcrpc/2010-10-27T13:29:24+00:00monthlyhttp://prostatecancerinfolink.net/2010/06/06/sunday-at-the-asco-annual-meeting/2010-10-27T11:50:02+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/26/uspstf-delays-november-meeting-and-decision-on-prostate-cancer-screening/2010-10-27T14:00:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/25/gene-based-therapy-for-localized-prostate-cancer/2010-10-25T15:14:14+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/25/prostate-cancer-news-reports-monday-october-25-2010/2010-10-25T14:37:15+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/25/socioeconomic-status-and-outcomes-after-prostate-cancer-treatment/2010-10-25T13:02:16+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/23/is-metabolic-syndrome-a-risk-factor-for-suboptimal-response-to-adt/2010-10-23T10:25:47+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/21/fda-formalizes-warning-of-cardivascular-risks-for-lhrh-agonists/2010-10-22T16:24:42+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/22/first-line-surgical-management-of-high-risk-localized-and-locally-advanced-prostate-cancer/2010-10-22T12:45:48+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/21/eighth-us-proton-beam-radiation-therapy-center-now-open/2011-11-15T12:32:24+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/21/fsh-receptor-and-imaging-of-extracapsular-prostate-cancer/2010-10-22T03:31:28+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/21/ralp-as-a-treatment-for-prostate-cancer-in-hiv-positive-patients/2010-10-21T11:41:30+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/20/5-year-outcomes-of-patients-treated-with-ralp-at-a-high-volume-specialty-center/2010-10-21T14:10:20+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/20/from-partin-tables-to-a-partin-nomogram-a-2010-update/2011-11-22T21:47:11+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/20/possible-small-increase-in-risk-for-colon-cancer-among-pca-patients/2010-10-20T11:55:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/20/vitamin-e-derivative-active-against-prostate-cancer-tumors-in-mice/2010-10-20T11:18:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/19/a-new-review-of-recent-clinical-outcomes-after-hifu/2011-03-20T15:27:58+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/19/understanding-your-clinicians-mindset-about-active-surveillance/2010-10-19T20:39:41+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/18/multifocal-high-grade-prostatic-epithelial-neoplasia-and-prostate-cancer-risk/2010-10-18T21:57:08+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/16/terminal-prostate-cancer-quality-of-death-and-hospice-care/2011-02-28T18:40:30+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/15/is-trofex-a-possible-replacement-imaging-agent-for-combidex/2010-10-18T01:08:11+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/15/xmrv-and-prostate-cancer-a-brief-update/2010-10-15T12:33:25+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/15/adt-associated-weight-change-in-the-real-world/2010-10-16T21:01:55+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/14/is-msmb-the-next-great-thing-in-prostate-cancer-testing/2010-10-15T00:49:43+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/14/outcomes-from-a-watchful-waiting-protocol-for-localized-prostate-cancer/2010-10-15T21:32:34+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/14/satisfaction-after-surgery-for-localized-prostate-cancer/2010-10-16T00:46:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/13/chemohormonal-therapy-ebrt-for-treatment-of-locally-advanced-prostate-cancer/2010-10-16T13:24:59+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/13/prolaris-prognostically-accurate-but-of-limited-utility/2010-11-06T14:40:05+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/13/clinical-implications-of-an-initial-diagnosis-of-asap/2010-10-13T11:06:06+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/12/compassionate-use-trial-of-abiraterone-acetate-in-mcrpc-to-start-soon/2010-12-04T06:39:04+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/12/psa-based-triggers-for-treatment-in-active-surveillance-protocols/2010-10-15T01:05:42+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/11/abiraterone-acetate-extends-median-survival-by-3-9-months-in-mcrpc/2010-11-25T02:06:51+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/08/ask-the-nfl-to-support-prostate-cancer-awareness/2010-10-21T12:37:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/11/ceasar-study-to-compare-effectiveness-of-first-line-therapies-for-localized-prostate-cancer/2010-10-14T01:26:03+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/11/adt-bone-architecture-and-virtual-bone-biopsies/2010-11-04T20:25:20+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/11/the-prognostic-value-of-ctcs-in-low-volume-prostate-cancer/2010-10-16T23:32:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/09/are-all-lhrh-agonists-just-the-same/2010-10-10T16:38:23+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/08/theres-a-limit-to-the-benefits-of-high-fish-diets/2010-10-15T01:12:54+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/08/a-45-percent-reduction-in-prostate-cancer-specific-mortality-not-exactly/2010-10-13T01:38:27+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/05/clinical-success-and-the-management-of-low-risk-localized-prostate-cancer/2010-10-07T12:06:06+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/07/acid-suppressive-therapy-ketoconazole-in-men-with-crpc/2010-10-08T12:08:13+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/06/does-revenue-affect-a-urologists-treatment-recommendations/2010-10-15T02:16:34+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/06/dural-metastases-in-men-with-progressive-metastatic-crpc/2010-10-06T12:50:05+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/05/acute-and-late-radiation-toxicities-of-proton-beam-radiation-therapy/2010-10-05T17:09:23+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/04/results-of-first-phase-iii-abiraterone-acetate-trial-to-be-presented-at-esmo/2010-10-09T22:56:48+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/04/more-about-mice-and-men-and-doxirubicin-and-viagra/2010-10-04T15:20:13+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/02/report-provides-final-results-of-the-tropic-trial-of-cabazitaxel/2010-10-03T03:01:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/01/oncogenex-starts-up-phase-ii-trial-of-ogx-427-in-advanced-prostate-cancer/2010-10-02T02:06:23+00:00monthlyhttp://prostatecancerinfolink.net/2010/10/01/systems-biology-and-the-development-of-prostate-cancer/2010-10-01T10:56:30+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/30/oncogenex-announces-second-phase-iii-trial-of-custirsen-in-mcrpc/2010-09-30T19:25:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/30/external-validation-of-the-capra-scoring-system/2010-09-30T13:35:15+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/29/second-phase-iii-clinical-trial-of-mdv3100-in-mcrpc/2010-09-30T00:30:30+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/29/another-new-test-that-might-be-able-to-limit-need-for-biopsies/2010-09-29T23:57:01+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/29/psychosocial-distress-at-diagnosis-and-12-months-later/2010-11-25T13:44:24+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/28/radiation-therapy-for-localized-prostate-cancer/2010-09-28T13:23:13+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/28/is-free-circulating-dna-a-useful-marker-for-prostate-cancer/2010-09-30T23:53:55+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/28/pfizer-discontinues-phase-iii-clinical-trial-of-sutent-in-crpc/2010-09-28T12:04:18+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/27/pity-the-innocent-pomegranate/2011-02-28T12:03:13+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/27/does-alcohol-consumption-cause-prostate-cancer-revisited-yet-again/2010-09-27T18:07:25+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/27/zibotentan-not-effective-when-used-alone-in-treatment-of-mcrpc/2010-09-27T16:45:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/25/the-prostate-cancer-screening-controversy-an-evolving-risk-based-perspective/2010-11-15T14:56:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/24/gtx-says-selective-estrogen-receptor-agonist-induces-medical-castration/2010-09-24T15:52:46+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/24/predicting-risk-for-gleason-score-upgrades-in-non-surgical-patients/2010-09-24T12:21:10+00:00monthlyhttp://prostatecancerinfolink.net/2009/02/22/hifu-under-appreciated-or-over-promoted/2010-09-23T17:37:45+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/23/older-and-newer-drugs-in-the-management-of-crpc/2010-10-18T03:34:02+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/23/early-stage-data-on-inecalcitol-docetaxel-in-crpc/2010-12-06T03:11:49+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/22/gen-probe-submits-application-to-market-progensa-pca3-assay/2010-11-05T20:04:21+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/21/active-surveillance-and-pathological-outcomes-after-rp/2010-09-22T12:28:42+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/22/bladder-outlet-obstruction-a-common-side-effect-of-hifu/2010-09-22T12:13:12+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/22/normal-reference-psa-values-among-spanish-males-under-65-years-of-age/2011-09-07T11:24:19+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/22/limited-predictive-accuracy-of-endorectal-coil-mri/2010-09-24T13:08:19+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/21/what-primary-care-docs-know-and-do-about-prostate-cancer-testing/2010-09-23T02:02:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/21/neoadjuvant-hormone-therapy-for-patients-undergoing-first-line-radiation-therapy/2010-09-21T12:16:13+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/20/insurance-status-impacts-severity-of-prostate-cancer-at-diagnosis-in-us/2010-09-20T14:31:37+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/20/new-data-on-the-5-year-complications-of-radical-prostatectomy/2010-09-20T12:28:02+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/14/a-brief-hiatus-in-the-infolink-news-service/2010-09-20T12:25:00+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/20/the-top-prostate-cancer-specialists/2010-09-21T00:46:45+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/16/psa-test-can-predict-25-year-risk-in-60-year-old-men/2010-09-16T11:53:31+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/14/an-important-week-for-prostate-cancer-in-washington-dc/2010-09-14T14:03:51+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/14/data-published-from-phase-ii-trial-of-ogx-011-custirsen/2010-09-14T11:56:11+00:00monthlyhttp://prostatecancerinfolink.net/2009/05/31/asco-commentary-and-update-no-1/2010-09-14T11:43:34+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/14/no-sign-that-coffee-increases-risk-for-prostate-cancer/2010-09-14T11:34:53+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/13/improving-on-the-kattan-nomogram-through-use-of-genetic-data/2010-09-14T02:39:08+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/13/age-and-psa-level-at-initial-testing-may-significantly-impact-prostate-cancer-specific-mortality/2012-02-09T18:52:42+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/12/health-technology-cost-and-the-psa-test/2010-09-13T19:46:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/10/how-many-biopsy-cores-is-the-right-number-revised-and-revisited/2010-09-10T20:08:03+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/10/more-good-news-about-abiraterone-acetate/2010-10-21T10:17:22+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/09/how-many-biopsy-cores-is-the-right-number/2010-09-14T22:30:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/27/please-participate-in-on-line-qol-survey-based-prostate-cancer-study/2010-09-09T20:11:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/09/new-nerve-sparing-score-predicts-post-surgical-erectile-function/2010-10-05T18:55:53+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/08/intraductal-carcinoma-of-the-prostate-idcp/2010-10-11T16:19:22+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/08/better-ultrasound-technology-in-diagnosis-is-it-time-for-change/2010-09-10T11:35:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/25/the-prostate-cancer-wives-and-partners-bill-of-rights/2010-09-14T21:45:48+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/07/cytrx-announces-phase-ii-trial-of-bafetinib-in-crpc/2010-09-07T20:17:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/07/of-mice-and-men-and-low-carbohydrate-diets/2010-09-07T20:03:58+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/04/immediate-adjuvant-radiation-therapy-in-the-pt3-patient-post-surgery/2010-09-07T21:21:29+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/05/risk-for-late-recurrence-after-rp-confirming-what-we-thought-we-knew/2010-09-05T21:17:18+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/05/a-positive-signal-about-abiraterone-acetate/2010-09-06T09:59:10+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/03/ct-adt-vs-3d-crt-adt-for-first-line-treatment-of-high-risk-prostate-cancer/2010-09-03T18:23:50+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/03/is-there-an-optimal-management-for-localized-prostate-cancer/2010-09-03T18:39:24+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/02/immediate-vs-deferred-radical-prostatectomy-for-localized-prostate-cancer/2010-09-02T15:12:34+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/02/the-natural-history-of-low-risk-prostate-cancer/2010-09-06T00:09:45+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/01/the-empowered-patient-an-article-in-usa-today/2010-09-01T20:10:18+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/01/a-presidential-proclamation-for-prostate-cancer-awareness-month/2010-09-01T14:04:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/09/01/10021/2010-09-06T00:22:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/10/comorbidities-and-risk-for-prostate-cancer-specific-mortality/2010-09-01T10:16:01+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/31/effects-of-prostate-biopsy-on-voiding-and-erectile-function/2010-09-12T20:32:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/30/intra-operative-fire-during-ralp-a-surgical-complication-to-be-avoided-if-possible/2010-08-31T12:48:03+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/31/a-randomized-controlled-trial-of-diet-and-exercise-for-man-on-adt/2010-08-31T19:29:35+00:00monthlyhttp://prostatecancerinfolink.net/treatment/first-line-localized/surgery/radical-prostatectomy-history/2010-08-29T17:34:00+00:00weekly0.6http://prostatecancerinfolink.net/2010/08/29/from-suspicion-to-treatment-is-time-to-action-appropriate/2010-08-29T13:01:07+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/24/for-those-who-are-into-twitter/2010-08-27T13:27:52+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/26/the-value-of-second-line-treatment-for-men-with-biochemical-recurrence/2010-08-27T12:37:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/27/statins-and-cancer-is-the-idea-that-statins-affect-prostate-cancer-a-bust/2010-08-27T12:27:38+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/26/adjuvant-and-neoadjuvant-use-of-adt-in-management-of-prostate-cancer-today/2010-08-27T17:24:33+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/26/candian-practice-guideline-does-not-recommend-hifu/2010-08-26T15:49:33+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/26/lets-light-the-white-house-blue-in-september/2010-08-26T14:52:04+00:00monthlyhttp://prostatecancerinfolink.net/2010/05/04/lighting-up-the-white-house-in-september/2010-08-26T14:37:55+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/26/diet-and-supplement-use-in-the-prostate-cancer-prevention-trial/2010-08-26T12:32:04+00:00monthlyhttp://prostatecancerinfolink.net/2009/07/04/hifu-for-localized-prostate-cancer-a-series-of-172-uk-patients/2010-08-26T11:59:04+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/24/a-web-based-system-for-assessment-of-functional-recovery-post-rp/2010-08-26T11:01:43+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/25/effect-of-the-prosdex-decision-support-tool-on-attitudes-to-psa-testing/2010-08-25T22:10:56+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/23/costs-associated-with-5-years-of-care-for-newly-diagnosed-medicare-patients/2010-08-26T04:04:09+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/23/outcomes-of-hdr-brachytherapy-imrt-vs-very-high-dose-imrt-alone/2010-08-24T16:58:34+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/21/acupuncture-as-a-treatment-for-hot-flashes-associated-with-adt/2010-08-23T01:26:57+00:00monthlyhttp://prostatecancerinfolink.net/2010/08/20/rapid-increase-in-number-of-radical-prostatectomies-in-the-usa/2010-08-22T19:27:08+00:00monthlyhttp://prostatecancerinfolink.net/daily1.02012-02-14T02:28:48+00:00